0001548123-18-000314.txt : 20181119 0001548123-18-000314.hdr.sgml : 20181119 20181119162605 ACCESSION NUMBER: 0001548123-18-000314 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 35 CONFORMED PERIOD OF REPORT: 20180930 FILED AS OF DATE: 20181119 DATE AS OF CHANGE: 20181119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nu-Med Plus, Inc. CENTRAL INDEX KEY: 0001543637 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 453672530 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-54808 FILM NUMBER: 181192793 BUSINESS ADDRESS: STREET 1: 455 EAST 500 SOUTH, SUITE #203 CITY: SALT LAKE CITY STATE: UT ZIP: 84111 BUSINESS PHONE: 801-746-3570 MAIL ADDRESS: STREET 1: 455 EAST 500 SOUTH, SUITE #203 CITY: SALT LAKE CITY STATE: UT ZIP: 84111 10-Q 1 f10-q-q3-2018v5clean.htm QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED SEPTEMBER 30, 2018 UNITED STATES

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the quarterly period ended September 30, 2018


[   ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT


For the transition period from __________ to __________


Commission File Number 000-54808


NU-MED PLUS, INC.

(Exact name of registrant as specified in its charter)


Utah

45-3672530

(State or other jurisdiction of

(IRS Employer Identification No.)

incorporation or organization)


455 East 500 South, Suite 203, Salt Lake City, Utah                                               84111

 (Address of principal executive offices)

 (Zip Code)


(801) 746-3570

 (Registrant’s telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X]   No [  ]


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.  See definitions of “large accelerated filer,” “accelerated filer,”  “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large Accelerated filer ¨

Accelerated filer ¨

Non-accelerated filer  ¨

Smaller reporting company x

Emerging growth company x


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [  ]   No [X]


Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes [X]   No [  ]






Applicable Only to Issuers Involved in Bankruptcy Proceedings During the Preceding Five Years:


Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.


Not applicable.


Applicable Only to Corporate Issuers:


Class

Outstanding as of November 19, 2018


Indicate the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date.

40,934,375 shares of $0.001 par value common stock on November 19, 2018




TABLE OF CONTENTS


PART I

FINANCIAL INFORMATION

2

 

 

 

ITEM 1

FINANCIAL STATEMENTS

3

ITEM 2

MANAGEMENT’S DISCUSSION AND ANAYLSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

13

ITEM 3

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

17

ITEM 4

CONTROLS AND PROCEDURES

17


PART II

OTHER INFORMATION

17

 

 

 

ITEM 1

LEGAL PROCEEDINGS

17

ITEM 2

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

17

ITEM 3

DEFAULTS UPON SENIOR SECURITIES

18

ITEM 4

MINE SAFETY DISCLOSURE

18

ITEM 5

OTHER INFORMATION

18

ITEM 6

EXHIBITS

18

 

 

 

SIGNATURES

19

NU-MED PLUS, INC.

Condensed Balance Sheets


 

 

 

September 30, 2018

(unaudited)

December 31, 2017

ASSETS

 

 

 

Current assets

 

 

 

Cash

 $        168,262

 $         351,043

 

Prepaid expense

343,624

9,167

 

 

Total current assets

511,886

360,210

Long-term assets

 

 

 

Property and equipment, net

             40,565

             46,509

 

 

Total assets

   $        552,451

 $         406,719

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

 

 

Current liabilities

 

 

 

Accounts payable

$            11,430

$                     -

 

Accounts payable – related party

6,547

4,000

 

Accrued Expense

96,511

84,411

 

Equipment loan – current portion

9,399

9,399

 

Convertible Promissory Notes – Related party

230,100

230,100

 

 

Total current liabilities

353,987

327,910

Long-term liabilities

 

 

        Equipment loan – long-term portion

3,980

10,567

        Total liabilities

357,967

338,477

Commitments and contingencies

-

-

Stockholders' equity (deficit)

 

 

 

Preferred stock; $0.001 par value; 10,000,000 authorized; no shares issued and outstanding, respectively.

-

-

 

Common stock; $0.001 par value; 90,000,000 authorized; 40,934,375 and 37,563,125 shares issued and outstanding, as of September 30, 2018 and December 31, 2017, respectively.

        40,934

        37,564

 

Additional paid-in capital

4,716,827

3,728,836

 

Stock subscription payable

789,175

806,405

 

Accumulated deficit

(5,352,452)

(4,504,563)

 

 

Total stockholders' equity (deficit)

194,484

68,242

 

 

Total liabilities and stockholders' equity (deficit)

 $           552,451

 $         406,719





The accompanying notes are an integral part of these condensed financial statements.



4




Nu-Med Plus, Inc.

Condensed Statements of Operations

(Unaudited)


 

 

 

Three months ended September 30, 2018

Three months ended September 30, 2017

Nine months ended September 30, 2018

Nine months ended September

30, 2017

 

 

 

 

 

 

 

Revenue

 $                -   

 $              -   

$                 -

$                  -

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

General and administrative expense

40,064

31,831

87,191

49,293

 

Payroll expense

59,266

11,527

184,716

34,099

 

Rent expense

4,540

4,287

13,504

12,416

 

Professional and consulting fees

414,618

86,518

536,965

214,012

 

Depreciation expense

3,581

3,586

10,969

8,958

 

 

Total operating expenses

522,069

137,749

833,345

318,778

 

 

 

 

 

 

 

 

 

Operating Loss

(522,069)

(137,749)

(833,345)

(318,778)

 

 

 

 

 

Other income/expense

 

 

 

 

 

Interest expense

(4,779)

(5,228)

(14,544)

(13,880)

 

Amortization of debt discount

-

-

-

(21,508)

 

Gain on extinguishment of debt

-

-

-

6,716,358

 

Loss on derivative

-

-

-

(2,632,571)

 

 

Total other income/expense

(4,779)

(5,228)

(14,544)

4,048,399

 

Income tax expense

            -

            -

-

-

 

 

 

 

 

 

 

 

Net income (loss)

$ (526,848)

$ (142,977)

$ (847,889)

$  3,729,621

 

 

 

 

 

 

 

Basic income (loss) per share

$        (0.01)

$       (0.00)

$       ( 0.02)

$        0.10

 

Weighted average common shares

outstanding - basic

39,043,668

37,322,711

38,187,449

37,322,415

 

 

 

 

 

 

 

Diluted income (loss) per share

$        (0.01)

$       (0.00)

$       ( 0.02)

$        0.05

 

Weighted average common shares

outstanding - diluted

39,043,668

37,322,711

38,187,449

76,399,015


The accompanying notes are an integral part of these condensed financial statements.



5









Nu-Med Plus, Inc.

Condensed Statements of Cash Flows

(Unaudited)

 

 

 

Nine months ended September 30, 2018

Nine months ended  September 30, 2017

Cash flows from operating activities:

 

 

 

Net income (loss)

$ (847,889)

$  3,729,621

 

Adjustment to reconcile net income (loss) to net cash used in operating activities:

 

 

 

 

Depreciation and amortization

10,970

8,958

 

 

Gain on debt extinguishment

-

(6,716,358)

 

 

Stock-based compensation

182,061

-

 

 

Stock issued for services performed

309,000

24,949

 

 

Amortization of debt discount

-

21,508

 

 

Loss on derivative liability

-

2,632,571

 

 

Changes in operating assets and liabilities:

 

 

 

 

      (Increase) decrease in prepaid expenses

(4,457)

-

 

 

      (Decrease) increase in accounts payable

11,430

(5,065)

 

 

      Decrease in related party payables

2,547

(2,000)

 

 

     Increase (decrease) in accrued expense

12,100

14,486

 

 

Net cash used in operating activities

(324,238)

(291,330)

Cash flows from investing activities:

 

 

          Purchase of equipment

(5,026)

-

 

 

Net cash used in investing activities

(5,026)

-

Cash flows from financing activities

 

 

 

Proceeds from stock subscriptions payable

43,070

-

 

Proceeds from issuance of common stock

110,000

729,705

 

Payments on equipment loan

(6,587)

(14,012)

 

Payments on convertible notes payable

-

(27,500)

 

 

Net cash provided by financing activities

146,483

688,193

 

 

Net increase (decrease) in cash

(182,781)

396,863

Cash at beginning of period

351,043

12,450

Cash at end of period

$   168,262

$    409,313

Supplemental schedule of cash flow information

 

 

     Cash paid for interest

$       2,488

$         1,962

     Cash paid for income tax

          100

               -

Supplemental schedule of non-cash financing activities

 

 

     Equipment loan

-

35,970

     Common stock issued to settle subscription payable

60,300

-

     Common stock issued for prepaid services

495,000

-

The accompanying notes are an integral part of these condensed financial statements.



6






Nu-Med Plus, Inc.

Notes to the Condensed Financial Statements

September 30, 2018


NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS


Nu-Med Plus, Inc. is an emerging growth early stage medical device company principally engaged in the design, innovation, development, enhancement and commercialization of beginning, early, and selective later-stage quality medical devices. The Company's immediate focus is on a nitric oxide powder formulation that is 99% pure-with a one year shelf life, a "hospital" generator device with controls, plus built-in safety monitors, that delivers inhaled nitric oxide to replace expensive pressurized canisters, a compact mobile rechargeable device to deliver inhaled nitric oxide gas and a nitric oxide clinical unit, along with research into the application of nitric oxide in wound healing. The Company is incorporated in Utah.


NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


a. Basis of Interim Financial Statement Presentation


The accompanying unaudited financial statements have been prepared by the Company pursuant to accounting principles generally accepted in the United States of America.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with rules and regulations of the Securities and Exchange Commission.  The information furnished in the interim financial statements includes normal recurring adjustments and reflects all adjustments which, in the opinion of management, are necessary for a fair presentation of such financial statements.  Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim financial statements be read in conjunction with the Company’s most recent audited financial statements and notes thereto included in its December 31, 2017 financial statements.  Operating results for the three and nine months ended September 30, 2018 are not necessarily indicative of the results that may be expected for the year ending December 31, 2018.


b. Reclassification of operating expenses


The Company has made a reclassification of the 2017 operating expenses that affects general and administrative expense and professional and consulting fees.  In the previously published 2017 financial statement presentations legal fees were included in general and administrative expenses.  In these accompanying unaudited financial statements those legal expenses have been reclassified to professional and consulting fees for comparative purposes, as in the 2018 financial presentation legal fees are included in the professional and consulting fee operating expenses.

  

c. Revenue Recognition


The Company is currently developing its products. It is anticipated that revenue will be recognized on product sales once the product has been shipped to the customers, persuasive evidence of an agreement exists, the price is fixed or determinable, and collectability is reasonably assured.


d. Estimates


The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.



7







NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)


e. Fair Value


Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  FASB Accounting Standards Codification (“ASC”) Topic 820 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:


Level 1 - Quoted market prices in active markets for identical assets or liabilities;

 

Level 2 - Inputs other than level one inputs that are either directly or indirectly observable; and


Level 3 - Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.


Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is observable.


All cash, accounts receivable, accounts payable and accrued liabilities are carried at cost, which approximates fair value due to the short-term nature of these financial instruments.  Additionally, we measure certain financial instruments at fair value on a recurring basis.


f. Cash and Cash Equivalents


The Company considers all deposit accounts and investment accounts with an original maturity of 90 days or less to be cash equivalents.  


g. Property and Equipment


Property and equipment items are stated at cost.  Expenditure for minor repairs, maintenance, and replacement parts which do not increase the useful lives of the assets are charged to expense as incurred. Expenditures exceeding $500 for new assets, or that increase the useful life of existing assets, are capitalized.  Depreciation is computed using the straight-line method.  The lives over which the property and equipment is depreciated are five to seven years.


h. Earnings per Share


The computation of earnings per share of common stock is based on the weighted average number of shares outstanding during the period of the financial statement as follows:


Diluted earnings per share is computed using the weighted average number of common shares plus dilutive common share equivalents outstanding during the period. For the three months ended September 30, 2018 and September 30, 2017 there were no common stock equivalents from outstanding convertible notes included in the calculation.  For the nine months ended September 30, 2018 and September 30, 2017 there were -0- and 39,076,600 common stock equivalents from outstanding notes included in the calculation.  As of September 30, 2018 there were 32,294,231 potentially dilutive shares related to convertible notes and 3,152,950 potentially dilutive shares related to subscription payables that needed to be considered as common stock equivalents.  The common stock equivalents were excluded from the calculation of diluted earnings per share because the effect these common stock equivalents would have been anti-dilutive as of September 30, 2018.



8







NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)


Earnings per share are shown, both basic and diluted, on the statement of operations.


i. Income Taxes


Deferred taxes are provided on an asset and liability approach whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.


j. Equity Instruments Issued for Non-Cash Items


In accordance with ASC Topic 718, the Company records equity instruments issued for non-cash items at the grant-date fair value of the equity instruments issued.


k. Recent Accounting Pronouncements


Public Law No. 115-97, known as the Tax Cuts and Jobs Act “the “Tax Act”). Enacted on December 22, 2017, reduced the U.S. federal corporate tax rate from 35% to 21% effective January 1, 2018.  Also, on December 22, 2017, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 118 (“SAB 118”), which provides guidance on accounting for tax effects of the Tax Act.  SAB 118 provides a measurement period of up to one year from the enactment date to complete the accounting.  Any adjustments during this measurement period will be included in net earnings from continuing operations as an adjustment to income tax expense in the reporting period when such adjustments are determined.  As the Company has net operating loss carryforwards which will offset tax liability for the coming year or years, no adjustments for the effect of the income tax rate change is reflected in our financial statements.


In February 2018, the Financial Standards Accounting Board (“FASB”) issued Accounting Statement Update No. 2018-02, “Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.”  This ASU allows a reclassification from accumulated other comprehensive income (“AOCI”) to retained earnings for certain income tax effects stranded in AOCI as a result of the Tax Act.  The reclassification eliminates the stranded tax effects resulting from the Tax Act and is intended to improve the usefulness of information reported to financial statement users.  ASU No. 2018-02 is effective for reporting periods beginning on January 1, 2019; early adoption is permitted. The Company does not currently have amounts to be reclassified under this and therefore believes it will not have an impact on its financial statements and statements of operations.


In June 2018, the FASB issued ASU No. 2018-07, “Compensation — Stock Compensation (Topic 718),” (“ASU 2018-07”). ASU 2018-07 is intended to reduce cost and complexity of financial reporting for non-employee share-based payments. Currently, the accounting requirements for non-employee and employee share-based payments are significantly different. ASU 2018-07 expands the scope of Topic 718, which currently only includes share-based payments to employees, to include share-based payments to non-employees for goods or services. Consequently, the accounting for share-based payments to non-employees and employees will be substantially aligned. This ASU supersedes Subtopic 505-50, “Equity — Equity-Based Payments to Nonemployees”. The amendments to ASU 2018 - 07 are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than a company’s adoption date of ASU No. 2014-09, (Topic 606), “Revenue from Contracts with Customers”. The Company is currently evaluating ASU 2018-07 and its impact on its condensed consolidated financial statements or disclosures.



9







In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders' equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders' equity presented in the balance sheet must be provided in a note or separate statement. The analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. This final rule is effective on November 5, 2018. The Company is in the process of evaluating the impact of the final rule on its consolidated financial statements.


The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows.  Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.


NOTE 3 - GOING CONCERN


The Company continues to accumulate significant operating losses and has an accumulated deficit of $5,352,452 at September 30, 2018.  The funds on hand as of September 30, 2018, will not be sufficient to enable it to execute its business plan and funding through the sale of equity capital and short term related party and other shareholder loans in order to meet the planned expenditures for development, operations, and administrative cost over the next 12 months will be required. Planned expenditures are approximately $1,200,000 for the next twelve months. If plans to obtain further financing prove to be insufficient to fund operations, continued viability could be at risk.  These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance of these financial statements.  The financial statements do not include any adjustments that might result from the outcome of these uncertainties.


The Company acknowledges that the funds on hand as of September 30, 2018, will not be sufficient to enable it to execute its business plan and funding through the sale of equity capital and short term related party and other shareholder loans in order to meet the planned expenditures for development, operations, and administrative cost over the next 12 months will be required. Planned expenditures are approximately $1,200,000 for the next twelve months. The Company is currently funded through December 31, 2018. If plans to obtain further financing prove to be insufficient to fund operations, continued viability could be at risk.


NOTE 4 – PROPERTY AND EQUIPMENT


Property and equipment and related accumulated depreciation consisted of the following at September 30, 2018, and December 31, 2017:


 

September 30, 2018

 

December 31, 2017

 

 

 

 

 

 

Equipment

$                   90,368

 

$                      85,343

 

Accumulated depreciation

(49,803)

 

(38,834)

 

 

 

 

 

 

     Total Fixed Assets

$                    40,565

 

$                      46,509

 


Depreciation expense for the nine months ended September 30, 2018 and 2017 was $10,969 and $8,958, respectively.




10






NOTE 5 - PREFERRED STOCK


On October 19, 2011, the Company filed Articles of Incorporation with the State of Utah so as to authorize 10,000,000 shares of preferred stock having a par value of $0.001 per share. No preferred shares are issued or outstanding at September 30, 2018.


NOTE 6 - COMMON STOCK


Subscription Payable:


As of September 30, 2018, the Company has a subscription payable of $789,175, for which they have the obligation to issue 3,152,950 shares of restricted common stock.  


In February 2017, the Company entered into a stock purchase agreement with a related party, significant shareholder and debt holder (the “buyer”), under which the buyer may purchase up to $700,000 in shares of common stock at $0.25 per share. We have received $693,605 under this agreement as of the close of the subscription window on February 1, 2018, and of the corresponding 2,774,420 shares subscribed there are 2,734,420 shares that have yet to be issued as of the date of this report.


In September 2017, the Company entered into another stock purchase agreement with the buyer, under which the buyer may purchase up to $400,000 in shares of common stock at $0.25 per share.  The agreement expired on August 30, 2018.  As of September 30, 2018, we have received $103,070 under this agreement for 412,280 shares, which have not been issued as of the date of this report.  (See also Note 9 for subsequent investment by this related party).


Common Stock Issued to Officer:


In February 14, 2018 the Company announced that the consulting agreement with the Chief Financial Officer (Mr. Merrell) was terminated effective December 31, 2017, and that a new agreement was entered into effective January 1, 2018 under which Mr. Merrell would receive 2,000,000 shares of restricted common stock, vesting at 500,000 shares per year, for his service.  The term of the agreement is for one year, renewable for one year extensions up to four years.  The Company issued all 2,000,000 shares to Mr. Merrell on August 20, 2018.  Any common shares not earned during the four-year period are to be returned or cancelled.  An expense of $150,000 was recorded for the nine-month period ended September 30, 2018, which represents the fair value of the stock vested during that reporting period.  A charge will be made each quarter as the shares are earned under the provisions of the agreement until such time as all shares have been earned.


Common Stock Issued for Cash:


In May 2018, the Company entered into three stock subscriptions agreements with two investors.  The subscriptions gave the investors the right to purchase up to 440,000 shares of restricted common stock at $0.25 per share.  The Company received $110,000 under these subscription agreements and issued the 440,000 shares of restricted stock in June to fully satisfy its obligations under the agreements.    


Common Stock Issued for Services:


In September 2018, the Company issued 650,000 shares of stock to two consultants.  Of the shares, 150,000 were issued under a consulting contract for services rendered and vested upon issue and 500,000 shares of restricted stock were issued to a consultant for services rendered and to be rendered through June 1, 2019.  Consulting expenses amounting to $309,000 have been recorded during the nine-month period ended September 30, 2018.  A prepaid expense of $330,000 is recorded and will be amortized over the term of the consulting agreement.

  



11






NOTE 7 – CONVERTIBLE PROMISSORY NOTES


$100,000 Convertible Promissory Note

On November 12, 2012, the Company issued a $100,000 convertible promissory note to SCS, a related party and significant shareholder, as compensation for services provided and to be provided during the period April 1, 2012 through March 31, 2013.  The note is due on demand, bears annual interest at 5.5%, and is convertible into shares of common stock at a conversion price to be agreed upon immediately prior to conversion.  On September 27, 2013, the Company amended the note to include a conversion price which of $0.01 per share for all unpaid principal and interest.  As of September 30, 2018 and December 31, 2017 interest accrued, but unpaid, was $35,762 and $31,629, respectively.


$130,100 Convertible Promissory Note

Prior to 2015, the Company entered into a convertible promissory note with SCS, a related party and significant shareholder, due on demand, bearing interest at 8% per annum, unsecured and convertible at $0.01 per share, with a price protection provision to a lower conversion price.  The balance of this note was $130,100 at September 30, 2018 and December 31, 2017 with accrued interest balances of $57,774 and $49,953, respectively.


NOTE 8 - COMMITMENTS AND CONTINGENCIES


Operating Lease Obligations


The Company entered into a lease for office space in February 2017 for $950 per month.  In November 2017 the Company signed a six-month extension of the lease with a lease payment of $978 per month. In July 2018 the Company signed a one-year extension to the lease with a monthly lease payment of $1,008.  Obligations under this lease are as follows:


 

    2018

    2019

    2020

Office lease

 $    3,024

$         8,063

$                   -


In 2017 the Company entered into a 24-month lease for a nitric oxide analyzer, with a monthly payment of $1,014 per month.  


Obligations under the equipment lease are as follows:


 

2018

2019

2020

Equipment lease

 $    3,042

$    12,167

$                   -


The lease is a capital lease, with the option to purchase at the end of the lease term.  The Company plans to exercise the purchase option under the lease, whereby 70% of the lease payments will be applied toward the purchase price of the equipment.


NOTE 9 - SUBSEQUENT EVENTS


On October 18, 2018 the company agreed to amend the stock purchase agreement entered into in September 2017 with the buyer, under which the buyer may purchase up to $400,000 in shares of common stock at $0.25 per share. (see Note 6).  The agreement had an expiration date of August 30, 2018.  Upon agreeing to extend the expiration date to August 30, 2019, the Company accepted $25,000 under that agreement, under which the buyer may purchase up to $400,000 in shares of common stock at $0.25 per share.  A total of $128,070 has been received under this agreement, there are 512,280 shares of restricted common stock that will be issued in satisfaction of the Company's obligation under those agreements.  


On October 24, 2018 the Company entered into stock subscription agreements with two individuals under which



12






they may purchase up to $35,000 in shares of common stock at $0.25 per share.  The Company accepted $35,000 under those agreements on October 24, 2018, and there are 140,000 shares of restricted common stock that will be issued in satisfaction of the Company’s obligation under those agreements.  


The Company has evaluated subsequent events pursuant to ASC Topic 855 and has determined that there are no other events that require disclosure as of the date of issuance.


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations


Special Note Regarding Forward-Looking Statements


Certain statements in this Report constitute “forward-looking statements.”  Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Factors that might cause such a difference include, among others, uncertainties relating to general economic and business conditions; industry trends; changes in demand for our products and services; uncertainties relating to customer plans and commitments and the timing of orders received from customers; announcements or changes in our pricing policies or that of our competitors; unanticipated delays in the development, market acceptance or installation of our products and services; changes in government regulations; availability of management and other key personnel; availability, terms and deployment of capital; relationships with third-party equipment suppliers; and worldwide political stability and economic growth. The words “believe,” “expect,” “anticipate,” “intend” and “plan” and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made.


Critical Accounting Policies and Estimates


The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the Financial Statements and accompanying notes.  Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates under different assumptions or conditions. 

 

The Company’s accounting policies are more fully described in Note 2 of the audited financial statements in our recently filed Form 10-K.  As discussed in Note 2, the preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about the future events that affect the amounts reported in the financial statements and the accompanying notes. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances.  Actual differences could differ from these estimates under different assumptions or conditions.  The Company believes that the following addresses the Company’s most critical accounting policies.


When we begin generating revenue we will recognize revenue in accordance with ASC 606, Revenue From Contracts with Customers, issued by the FASB and IASB on May 28, 2014, with an implementation date beginning December 15, 2017.  Under the guidelines provided by ASC 606 an entity recognizes revenue to depict the transfer of goods and services to customers in amounts that reflect the consideration to which the entity expects to be entitled in exchange for those goods or services.  


Revenue is recognized in accordance with that core principal by applying the following steps:

Step 1 – Identify the contract(s) with a customer

Step 2 – Identify the performance obligation in the contract



13






Step 3 – Determine the transaction price

Step 4 – Allocate the transaction price to the performance obligations in the contract

Step 5 – Recognize revenue when, or as, the entity satisfies a performance obligation.


Our policy for our allowance for doubtful accounts is maintained to provide for losses arising from customers’ inability to make required payments.  If there is deterioration of our customers’ credit worthiness and/or there is an increase in the length of time that the receivables are past due greater than the historical assumptions used, additional allowances may be required.


We account for income taxes in accordance with the Tax Cuts and Jobs Act and SAB 118


BUSINESS OVERVIEW


NU-MED PLUS, INC., a Utah corporation (“NU-MED” or the “Company”) was incorporated in October 2011 in the state of Utah to develop, manufacture and market new technologies utilizing nitric oxide in the medical device field, primarily through the creation of a nitric oxide generating compound formulation and delivery systems.  To date we have developed a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications. NU-MED is headquartered in Salt Lake City, Utah.


Business


The mission of NU-MED is to design, develop, and market technologies in the medical device field. Our technologies will focus on market niches in high growth trend areas.  We hope each developed technology will fill a current need in medical procedures by improving upon an existing technology or device, or by designing a device to serve a need that is clearly defined and acknowledged by medical professionals.


NU-MED is a medical device company principally engaged in the design, innovation, development, enhancement and commercialization of beginning, early, and selective later-stage quality medical devices. Our immediate focus is on the creation of a nitric oxide formulation, a hospital and clinical inhaled nitric oxide (“NO”) generator and a mobile rechargeable device to deliver nitric oxide gas to offer solutions to hospitals, health systems and the medical community throughout the world.


NU-MED PLUS has focused on the development of five distinct products for the delivery of nitric oxide. NU-MED products have not been fully developed; therefore, we have not made any submission for FDA approval under any medical use.

 

      1.  Nitric oxide proprietary formulation.


2. A hospital delivery device with controls and safety monitors built in that delivers inhaled nitric oxide to a patient at therapeutic levels.  This delivery system is intended for hospitals specifically intensive care units. The goal is to have a system that delivers a metered therapeutic dose (up to 40 ppm) of nitric oxide via a ventilator. The core technology allows dilution of nitric oxide to therapeutic levels to be accomplished without the use of injectors or valves. Safeguards such as concentration monitoring, flow and gas purity would be standard.


3.  A clinical delivery unit that is designed for treatment in an office or physician’s clinic. A unit powered by a wall outlet, administration of the nitric oxide would be via cannula or non-rebreather face mask


4. A compact, mobile/portable rechargeable device to deliver inhaled nitric oxide gas.  The portable system necessitates a design which can be deployed where a reliable source of power is not available or is difficult to access. The key feature is a rechargeable battery pack that powers the unit for the full duration of a therapeutic session. It can be recharged using existing electrical sources, a solar array or other alternative energy source. The



14






unit is designed as a low power but fully functional nitric oxide delivery system for inhalation therapy, that can be used as a transport device during the movement of a patient or as a delivery device in those remote areas of the world that do not currently have electrical power readily available.


5. A unit that is one of the world’s first nitric oxide dilution systems designed for research. A patent pending technology utilizes pure 100% nitric oxide from a pressurized tank source and dilutes it with air or other non-reactive diluent gas to provide a 1 to 500 ppm source of high purity nitric oxide for investigational applications.


NU-MED has one of its research units placed with a research group that is currently using the unit in an animal study.  NU-MED will receive data during the study.


LIQUIDITY AND CAPITAL RESOURCES


At September 30, 2018, we had assets of $552,451 with current assets of $511,886 and liabilities of $357,967. Our current assets consisted primarily of cash in the amount of $168,262 and prepaid expenses in the amount of $343,624. We currently have no revenue and have had to rely on loans from shareholders or sale of our stock to cover expenses.  Without additional capital, we will not be able to stay in business and move our business plan forward. We anticipate, based on our preliminary budgets, that we will need $300,000 in additional financing for the next twelve months to cover our corporate overhead and need an additional $900,000 to cover ongoing product development. Since we will not have a commercial product in the next twelve months, we will have to continue to rely on outside funding to support our operations and product development and testing efforts.  Given the financial state of NU-MED, we will not be able to seek traditional bank financing and have to rely on private stock sales as well as potential loans from investors and shareholders.  At this time, we have a stock subscription agreement under which the investor has the right to purchase up to $400,000 of restricted common stock at a price of $0.25 per share.  In October 2018, agreement was reached to extend the expiration date of this agreement to August 30, 2019.  During the nine-month period ended September 30, 2018, we accepted $43,070 under this agreement and $110,000 under additional stock subscriptions agreements entered into with qualified investors.  We cannot estimate the full costs to bring our proposed product to market or the timing of such commercialization.  Given the nature of our product being in the medical field, testing is very expensive and we would need more capital prior to completing the testing phase. Any refinement or modification of the product after the prototype is developed would also require additional capital. At this time, we will have to continue to rely on outside capital and a budget that may require adjustment as we move further in the product development phase.


RESULTS OF OPERATIONS


FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018 AND 2017


For the three months ended September 30, 2018 and September 30, 2017, we had no revenues and operating expenses of $522,069 and $137,749, respectively.  For the three months ended September 30, 2018 and September 30, 2017 we had other expenses of $4,779 and $5,228, respectively.  For the three months ended September 30, 2018 and September 30, 2017, we had net losses of $526,848 and $142,977, respectively.  Consulting expenses increased by $366,523 to $411,346 in the three months ended September 30, 2018 compared to $48,532 for the three months ended September 30, 2017 as we accelerated the work by our FDA consultant to put into place the documentation required for the FDA submission process and initiated our investor relations program.  Lab supplies were $6,308 lower for the three months ended September 30, 2018 compared to the three months ended September 30, 2017, as the majority of the parts needed for the hospital unit were purchased in 2017.We will be dependent on outside capital to support operations for the foreseeable future and at this time do not have any commitments for additional capital beyond the $400,000 stock subscription earlier mentioned.  We do not anticipate any revenue for the foreseeable future as our products are still in the development stage.




15






FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2018 AND 2017


For the nine months ended September 30, 2018 and September 30, 2017, we had no revenues and operating expenses of $833,345 and $318,778, respectively.  The increased operating expenses primarily resulted from a $422,684 increase in consulting expense, growing to $516,058 for the nine-month period ended September 30, 2018 compared to $93,374 for the nine-month period ended September 30, 2017. For the nine months ended September 30, 2018 we had other expenses of $14,544.  For the nine months ended September 30, 2017 we had other income of $4,048,399, primarily resulting from a $6,716,358 gain on extinguishment of debt, offset by a loss on derivative of $2,632,571.  For the nine months ended September 30, 2018 we had a net loss of $847,889.  For the nine months ended September 30, 2017, we had net income of $3,729,621 due to the gain on extinguishment earlier discussed.  We will be dependent on outside capital to support operations for the foreseeable future and at this time do not have any commitments for additional capital beyond the $400,000 stock subscription earlier mentioned.  We do not anticipate any revenue for the foreseeable future as our products are still in the development stage.


SUMMARY OF BALANCE SHEET INFORMATION


The table below represents a summary of our condensed consolidated balance sheets at September 30, 2018 and December 31, 2017:


September 30, 2018

December 31, 2017


Cash and cash equivalents

$  168,262

$ 351,043

Total current assets

    511,886

   360,210

Total assets

    552,451

   406,719

Total liabilities

    357,967

   338,477

Accumulated deficit

(5,352,452)

              (4,504,563)

Total stockholders’ equity

    194,484

     68,242


Cash and cash equivalents decreased by $182,781 at September 30, 2018 compared to December 31, 2017.  The decrease in cash is due to the payment of operating expenses and the increased costs of consultants as we work to finalize the design and building of our products, offset by cash received under stock subscription agreements.


Total liabilities increased by $19,490 at September 30, 2018 compared to December 31, 2017 primarily due to increases in accounts payable and accrued expenses, of which accrued interest on notes is the largest component.


Off-Balance Sheet Arrangements.


The Company does not have any off-balance sheet arrangements and it is not anticipated that the Company will enter into any off-balance sheet arrangements.


Forward-looking Statements


Our Company and our representatives may from time to time make written or oral statements that are “forward-looking,” including statements contained in this Quarterly Report and other filings with the Securities and Exchange Commission and in reports to our Company’s stockholders. Management believes that all statements that express expectations and projections with respect to future matters, as well as from developments beyond our Company’s control including changes in global economic conditions are forward-looking statements within the meaning of the Act. These statements are made on the basis of management’s views and assumptions, as of the time the statements are made, regarding future events and business performance. There can be no assurance, however, that management’s expectations will necessarily come to pass. Factors that may affect forward- looking statements include a wide range of factors that could materially affect future developments and performance, including the following:



16







Changes in Company-wide strategies, which may result in changes in the types or mix of businesses in which our Company is involved or chooses to invest; changes in U.S., global or regional economic conditions, changes in U.S. and global financial and equity markets, including significant interest rate fluctuations, which may impede our Company’s access to, or increase the cost of, external financing for our operations and investments; increased competitive pressures, both domestically and internationally, legal and regulatory developments, such as regulatory actions affecting environmental activities, the imposition by foreign countries of trade restrictions and changes in international tax laws or currency controls; adverse weather conditions or natural disasters, such as hurricanes and earthquakes, labor disputes, which may lead to increased costs or disruption of operations.


This list of factors that may affect future performance and the accuracy of forward-looking statements is illustrative, but by no means exhaustive. Accordingly, all forward-looking statements should be evaluated with the understanding of their inherent uncertainty.


Item 3.  Quantitative and Qualitative Disclosures About Market Risk.


Not applicable.


Item 4.  Controls and Procedures.


Evaluation of Disclosure Controls and Procedures


Our management, including our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15 or 15d-15e) under the Exchange Act as of the end of the period covered by this report.  Our management does not expect that our disclosure controls and procedures will prevent all error and all fraud.  In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, not matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.


Based on that evaluation, as of September 30, 2018, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.  


Changes in internal control over financial reporting


There have been no changes in internal control over financial reporting that occurred during the last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the internal control over financial reporting.


PART II - OTHER INFORMATION


ITEM 1.  Legal Proceedings


None.


ITEM 1A.  Risk Factors


Not applicable




17






ITEM 2.  Unregistered Sales of Equity Securities and Use of Proceeds


Recent Sales of Unregistered Securities


None.


Other Securities Transactions


None.

 

Use of Proceeds of Registered Securities


None.


Purchases of Equity Securities by Us and Affiliated Purchasers


During the nine months ended September 30, 2018, we have not purchased any equity securities nor have any officers or directors of the Company.


Item 3.  Defaults Upon Senior Securities


Not applicable.


ITEM 4.  Mine Safety Disclosure


Not applicable.


ITEM 5.  Other Information


None.


ITEM 6.  Exhibits

 

a) Index of Exhibits:

 

Exhibit Table #

Title of Document

Location


31.1

Rule 13a-14(a)/15d-14a(a) Certification – CEO

This filing


31.2

Rule 13a-14(a)/15d-14a(a) Certification – CFO

This filing


32

Section 1350 Certification – CEO & CFO

This filing


101.INS

 XBRL Instance


101.XSD 

XBRL Schema


101.CAL

 XBRL Calculation


101.DEF

 XBRL Definition


101.LAB

XBRL Label


101.PRE

XBRL Presentation



18






SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


NU-MED PLUS, INC.,

(Registrant)



November 19, 2018

By:  /s/ Jeffrey L. Robins

Jeffrey L. Robins, CEO, Principal Executive Officer


November 19, 2018

By: /s/Keith L. Merrell

Keith L. Merrell, CFO/Principal Accounting

       Officer




19





 

EX-31 2 ex31-1.htm 302 CERTIFICATION OF CEO Exhibit 31

Exhibit 31.1

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


     I, Jeffrey L. Robins certify that:


     1.   I have reviewed this Quarterly Report on Form 10-Q of Nu-Med Plus, Inc.;


     2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


     3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;


     4.   The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:


a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;  


b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c)

Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d)

Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and


     5.   The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions);


a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and


b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.


Dated: 11/19/2018                           Signature:/s/Jeffrey L. Robins

                                                         Jeffrey L. Robins

                                                         Chief Executive Officer and Principal Executive Officer




EX-31 3 ex31-2.htm 302 CERTIFICATION OF CFO Exhibit 31

Exhibit 31.2

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


     I, Keith L. Merrell certify that:


     1.   I have reviewed this Quarterly Report on Form 10-Q of Nu-Med Plus, Inc.;


     2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


     3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;


     4.   The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:


a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c)

Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d)

Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and


     5.   The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions);


a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and


b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.


Dated: 11/19/2018                           Signature:/s/Keith L Merrell

                                                          Keith L. Merrell

                                                          Principal Financial Officer and CFO




EX-32 4 ex32.htm 906 CERTIFICATION Exhibit 32

Exhibit 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Nu-Med Plus, Inc. (the “Company”) on Form 10-Q for the period ending September 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), We, Jeffrey L. Robins, our Chief Executive Officer and Director and Keith L.Merrell, our Chief/Principal Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


     (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


     (2)  The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


Dated: 11/19/2018                             /s/Jeffrey L. Robins

                                                           Jeffrey L. Robins

                                                           Chief Executive Officer and Director



Dated: 11/19/2018                            /s/Keith L. Merrell

                                                          Keith L. Merrell

                                                          Principal Financial Officer and CFO




EX-101.PRE 5 numd-20180930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.INS 6 numd-20180930.xml XBRL INSTANCE DOCUMENT Nu-Med Plus, Inc. 0001543637 --12-31 NUMD Non-accelerated Filer Yes true true false false 2018 Q3 10-Q 2018-09-30 Utah 453672530 40934375 0.001 168262 351043 343624 9167 511886 360210 40565 46509 552451 406719 11430 0 6547 4000 96511 84411 9399 9399 230100 230100 353987 327910 3980 10567 357967 338477 0 0 0.001 10000000 0 0 0 0 0 0 0.001 0.001 90000000 90000000 40934375 40934375 37563125 37563125 40934 37564 4716827 3728836 -789175 -806405 -4504563 194484 68242 552451 406719 0 0 0 0 40064 31831 87191 49293 59266 11527 184716 34099 4540 4287 13504 12416 414618 86518 536965 214012 3581 3586 522069 137749 833345 318778 -522069 -137749 -833345 -318778 -4779 -5228 -14544 -13880 0 0 0 0 0 0 0 -2632571 -4779 -5228 -14544 4048399 0 0 0 0 -526848 -142977 -0.01 -0.00 -0.02 0.10 39043668 37322711 38187449 37322415 -0.01 -0.00 -0.02 0.05 39043668 37322711 38187449 76399015 -847889 3729621 10970 8958 0 6716358 182061 0 24949 0 -21508 0 2632571 -4457 0 11430 -5065 2547 -2000 12100 14486 -324238 -291330 -5026 0 -5026 0 43070 0 110000 729705 -6587 -14012 0 -27500 146483 688193 -182781 396863 351043 12450 168262 409313 2488 1962 100 0 0 35970 60300 0 495000 0 <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>Nu-Med Plus, Inc. is an emerging growth early stage medical device company principally engaged in the design, innovation, development, enhancement and commercialization of beginning, early, and selective later-stage quality medical devices. The Company's immediate focus is on a nitric oxide powder formulation that is 99% pure-with a one year shelf life, a &quot;hospital&quot; generator device with controls, plus built-in safety monitors, that delivers inhaled nitric oxide to replace expensive pressurized canisters, a compact mobile rechargeable device to deliver inhaled nitric oxide gas and a nitric oxide clinical unit, along with research into the application of nitric oxide in wound healing. The Company is incorporated in Utah. </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'><font style='display:none'>&#160;</font></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>a. Basis of Interim Financial Statement Presentation</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>The accompanying unaudited financial statements have been prepared by the Company pursuant to accounting principles generally accepted in the United States of America.&#160; Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with rules and regulations of the Securities and Exchange Commission.&#160; The information furnished in the interim financial statements includes normal recurring adjustments and reflects all adjustments which, in the opinion of management, are necessary for a fair presentation of such financial statements.&#160; Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim financial statements be read in conjunction with the Company&#146;s most recent audited financial statements and notes thereto included in its December 31, 2017 financial statements.&#160; Operating results for the three and nine months ended September 30, 2018 are not necessarily indicative of the results that may be expected for the year ending December 31, 2018.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>b. Reclassification of operating expenses</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>The Company has made a reclassification of the 2017 operating expenses that affects general and administrative expense and professional and consulting fees.&#160; In the previously published 2017 financial statement presentations legal fees were included in general and administrative expenses.&#160; In these accompanying unaudited financial statements those legal expenses have been reclassified to professional and consulting fees for comparative purposes, as in the 2018 financial presentation legal fees are included in the professional and consulting fee operating expenses.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>c. Revenue Recognition</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>The Company is currently developing its products. It is anticipated that revenue will be recognized on product sales once the product has been shipped to the customers, persuasive evidence of an agreement exists, the price is fixed or determinable, and collectability is reasonably assured. </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>d. Estimates</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. &nbsp;Actual results could differ from those estimates.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'><font style='display:none'>&#160;</font></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'>e. Fair Value</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. &nbsp;FASB Accounting Standards Codification (&#147;ASC&#148;) Topic 820 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value. &nbsp;The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>Level 1 - Quoted market prices in active markets for identical assets or liabilities;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>Level 2 - Inputs other than level one inputs that are either directly or indirectly observable; and</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>Level 3 - Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is observable.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>All cash, accounts receivable, accounts payable and accrued liabilities are carried at cost, which approximates fair value due to the short-term nature of these financial instruments. &nbsp;Additionally, we measure certain financial instruments at fair value on a recurring basis.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>f. Cash and Cash Equivalents</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>The Company considers all deposit accounts and investment accounts with an original maturity of 90 days or less to be cash equivalents. &nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>g. Property and Equipment</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>Property and equipment items are stated at cost. &nbsp;Expenditure for minor repairs, maintenance, and replacement parts which do not increase the useful lives of the assets are charged to expense as incurred. Expenditures exceeding $500 for new assets, or that increase the useful life of existing assets, are capitalized. &nbsp;Depreciation is computed using the straight-line method. &nbsp;The lives over which the property and equipment is depreciated are five to seven years.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>h. Earnings per Share</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>The computation of earnings per share of common stock is based on the weighted average number of shares outstanding during the period of the financial statement as follows:</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>Diluted earnings per share is computed using the weighted average number of common shares plus dilutive common share equivalents outstanding during the period.&#160; For the three months ended September 30, 2018 and September 30, 2017 there were no common stock equivalents from outstanding convertible notes included in the calculation.&#160; For the nine months ended September 30, 2018 and September 30, 2017 there were 0 and 39,076,600 common stock equivalents from outstanding notes included in the calculation.&#160; As of September 30, 2018 there were 32,294,231 potentially dilutive shares related to convertible notes and 3,152,950 potentially dilutive shares related to subscription payables that needed to be considered as common stock equivalents.&#160; The common stock equivalents were excluded from the calculation of diluted earnings per share because the effect these common stock equivalents would have been anti-dilutive as of September 30, 2018.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>Earnings per share are shown, both basic and diluted, on the statement of operations.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>i. Income Taxes</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>Deferred taxes are provided on an asset and liability approach whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. &nbsp;Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. &nbsp;Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>j. Equity Instruments Issued for Non-Cash Items</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>In accordance with ASC Topic 718, the Company records equity instruments issued for non-cash items at the grant-date fair value of the equity instruments issued. </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>k. Recent Accounting Pronouncements</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>reduced the U.S. federal corporate tax rate from 35% to 21% effective January 1, 2018.&#160; Also, on December 22, 2017, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 118 (&#147;SAB 118&#148;), which provides guidance on accounting for tax effects of the Tax Act.&#160; SAB 118 provides a measurement period of up to one year from the enactment date to complete the accounting.&#160; Any adjustments during this measurement period will be included in net earnings from continuing operations as an adjustment to income tax expense in the reporting period when such adjustments are determined.&#160; As the Company has net operating loss carryforwards which will offset tax liability for the coming year or years, no adjustments for the effect of the income tax rate change is reflected in our financial statements.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>In February 2018, the Financial Standards Accounting Board (&#147;FASB&#148;) issued Accounting Statement Update No. 2018-02, <i>&#147;Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.&#148;</i>&#160; This ASU allows a reclassification from accumulated other comprehensive income (&#147;AOCI&#148;) to retained earnings for certain income tax effects stranded in AOCI as a result of the Tax Act.&#160; The reclassification eliminates the stranded tax effects resulting from the Tax Act and is intended to improve the usefulness of information reported to financial statement users.&#160; ASU No. 2018-02 is effective for reporting periods beginning on January 1, 2019; early adoption is permitted. The Company does not currently have amounts to be reclassified under this and therefore believes it will not have an impact on its financial statements and statements of operations. </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify;line-height:11.4pt'><font style='quot,serif'>In June 2018, the FASB issued ASU No. 2018-07, &#147;Compensation &#151; Stock Compensation (Topic 718),&#148; (&#147;ASU 2018-07&#148;). ASU 2018-07 is intended to reduce cost and complexity of financial reporting for non-employee share-based payments. Currently, the accounting requirements for non-employee and employee share-based payments are significantly different. ASU 2018-07 expands the scope of Topic 718, which currently only includes share-based payments to employees, to include share-based payments to non-employees for goods or services. Consequently, the accounting for share-based payments to non-employees and employees will be substantially aligned. This ASU supersedes Subtopic 505-50, &#147;Equity &#151; Equity-Based Payments to Nonemployees&#148;. The amendments to ASU 2018 - 07 are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than a company&#146;s adoption date of ASU No. 2014-09, (Topic 606), &#147;Revenue from Contracts with Customers&#148;. The Company is currently evaluating ASU 2018-07 and its impact on its condensed consolidated financial statements or disclosures.</font></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify;line-height:12.0pt'>In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, <i>Disclosure Update and&nbsp;Simplification</i>, amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders' equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders' equity presented in the balance sheet must be provided in a note or separate statement. The analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. This final rule is effective on November 5, 2018. The Company is in the process of evaluating the impact of the final rule on its consolidated financial statements.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows.&#160; Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations. </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>NOTE 3 - GOING CONCERN</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>The Company continues to accumulate significant operating losses and has an accumulated deficit of $5,352,452 at September 30, 2018. &nbsp;The funds on hand as of September 30, 2018, will not be sufficient to enable it to execute its business plan and funding through the sale of equity capital and short term related party and other shareholder loans in order to meet the planned expenditures for development, operations, and administrative cost over the next 12 months will be required. Planned expenditures are approximately $1,200,000 for the next twelve months. If plans to obtain further financing prove to be insufficient to fund operations, continued viability could be at risk.&#160; These factors raise substantial doubt about the Company&#146;s ability to continue as a going concern for a period of one year from the issuance of these financial statements. &nbsp;The financial statements do not include any adjustments that might result from the outcome of these uncertainties.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>The Company acknowledges that the funds on hand as of September 30, 2018, will not be sufficient to enable it to execute its business plan and funding through the sale of equity capital and short term related party and other shareholder loans in order to meet the planned expenditures for development, operations, and administrative cost over the next 12 months will be required. Planned expenditures are approximately $1,200,000 for the next twelve months. The Company is currently funded through December 31, 2018. If plans to obtain further financing prove to be insufficient to fund operations, continued viability could be at risk. </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>a. Basis of Interim Financial Statement Presentation</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>The accompanying unaudited financial statements have been prepared by the Company pursuant to accounting principles generally accepted in the United States of America.&#160; Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with rules and regulations of the Securities and Exchange Commission.&#160; The information furnished in the interim financial statements includes normal recurring adjustments and reflects all adjustments which, in the opinion of management, are necessary for a fair presentation of such financial statements.&#160; Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim financial statements be read in conjunction with the Company&#146;s most recent audited financial statements and notes thereto included in its December 31, 2017 financial statements.&#160; Operating results for the three and nine months ended September 30, 2018 are not necessarily indicative of the results that may be expected for the year ending December 31, 2018.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>b. Reclassification of operating expenses</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>The Company has made a reclassification of the 2017 operating expenses that affects general and administrative expense and professional and consulting fees.&#160; In the previously published 2017 financial statement presentations legal fees were included in general and administrative expenses.&#160; In these accompanying unaudited financial statements those legal expenses have been reclassified to professional and consulting fees for comparative purposes, as in the 2018 financial presentation legal fees are included in the professional and consulting fee operating expenses.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>c. Revenue Recognition</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>The Company is currently developing its products. It is anticipated that revenue will be recognized on product sales once the product has been shipped to the customers, persuasive evidence of an agreement exists, the price is fixed or determinable, and collectability is reasonably assured. </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>d. Estimates</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. &nbsp;Actual results could differ from those estimates.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'>e. Fair Value</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. &nbsp;FASB Accounting Standards Codification (&#147;ASC&#148;) Topic 820 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value. &nbsp;The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>Level 1 - Quoted market prices in active markets for identical assets or liabilities;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>Level 2 - Inputs other than level one inputs that are either directly or indirectly observable; and</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>Level 3 - Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is observable.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>All cash, accounts receivable, accounts payable and accrued liabilities are carried at cost, which approximates fair value due to the short-term nature of these financial instruments. &nbsp;Additionally, we measure certain financial instruments at fair value on a recurring basis.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>f. Cash and Cash Equivalents</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>The Company considers all deposit accounts and investment accounts with an original maturity of 90 days or less to be cash equivalents. &nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>g. Property and Equipment</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>Property and equipment items are stated at cost. &nbsp;Expenditure for minor repairs, maintenance, and replacement parts which do not increase the useful lives of the assets are charged to expense as incurred. Expenditures exceeding $500 for new assets, or that increase the useful life of existing assets, are capitalized. &nbsp;Depreciation is computed using the straight-line method. &nbsp;The lives over which the property and equipment is depreciated are five to seven years.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>h. Earnings per Share</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>The computation of earnings per share of common stock is based on the weighted average number of shares outstanding during the period of the financial statement as follows:</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>Diluted earnings per share is computed using the weighted average number of common shares plus dilutive common share equivalents outstanding during the period.&#160; For the three months ended September 30, 2018 and September 30, 2017 there were no common stock equivalents from outstanding convertible notes included in the calculation.&#160; For the nine months ended September 30, 2018 and September 30, 2017 there were 0 and 39,076,600 common stock equivalents from outstanding notes included in the calculation.&#160; As of September 30, 2018 there were 32,294,231 potentially dilutive shares related to convertible notes and 3,152,950 potentially dilutive shares related to subscription payables that needed to be considered as common stock equivalents.&#160; The common stock equivalents were excluded from the calculation of diluted earnings per share because the effect these common stock equivalents would have been anti-dilutive as of September 30, 2018.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>Earnings per share are shown, both basic and diluted, on the statement of operations.</p> 0 0 0 39076600 32294231 <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>i. Income Taxes</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>Deferred taxes are provided on an asset and liability approach whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. &nbsp;Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. &nbsp;Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>j. Equity Instruments Issued for Non-Cash Items</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>In accordance with ASC Topic 718, the Company records equity instruments issued for non-cash items at the grant-date fair value of the equity instruments issued. </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>k. Recent Accounting Pronouncements</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>reduced the U.S. federal corporate tax rate from 35% to 21% effective January 1, 2018.&#160; Also, on December 22, 2017, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 118 (&#147;SAB 118&#148;), which provides guidance on accounting for tax effects of the Tax Act.&#160; SAB 118 provides a measurement period of up to one year from the enactment date to complete the accounting.&#160; Any adjustments during this measurement period will be included in net earnings from continuing operations as an adjustment to income tax expense in the reporting period when such adjustments are determined.&#160; As the Company has net operating loss carryforwards which will offset tax liability for the coming year or years, no adjustments for the effect of the income tax rate change is reflected in our financial statements.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>In February 2018, the Financial Standards Accounting Board (&#147;FASB&#148;) issued Accounting Statement Update No. 2018-02, <i>&#147;Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.&#148;</i>&#160; This ASU allows a reclassification from accumulated other comprehensive income (&#147;AOCI&#148;) to retained earnings for certain income tax effects stranded in AOCI as a result of the Tax Act.&#160; The reclassification eliminates the stranded tax effects resulting from the Tax Act and is intended to improve the usefulness of information reported to financial statement users.&#160; ASU No. 2018-02 is effective for reporting periods beginning on January 1, 2019; early adoption is permitted. The Company does not currently have amounts to be reclassified under this and therefore believes it will not have an impact on its financial statements and statements of operations. </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify;line-height:11.4pt'><font style='quot,serif'>In June 2018, the FASB issued ASU No. 2018-07, &#147;Compensation &#151; Stock Compensation (Topic 718),&#148; (&#147;ASU 2018-07&#148;). ASU 2018-07 is intended to reduce cost and complexity of financial reporting for non-employee share-based payments. Currently, the accounting requirements for non-employee and employee share-based payments are significantly different. ASU 2018-07 expands the scope of Topic 718, which currently only includes share-based payments to employees, to include share-based payments to non-employees for goods or services. Consequently, the accounting for share-based payments to non-employees and employees will be substantially aligned. This ASU supersedes Subtopic 505-50, &#147;Equity &#151; Equity-Based Payments to Nonemployees&#148;. The amendments to ASU 2018 - 07 are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than a company&#146;s adoption date of ASU No. 2014-09, (Topic 606), &#147;Revenue from Contracts with Customers&#148;. The Company is currently evaluating ASU 2018-07 and its impact on its condensed consolidated financial statements or disclosures.</font></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify;line-height:12.0pt'>In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, <i>Disclosure Update and&nbsp;Simplification</i>, amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders' equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders' equity presented in the balance sheet must be provided in a note or separate statement. The analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. This final rule is effective on November 5, 2018. The Company is in the process of evaluating the impact of the final rule on its consolidated financial statements.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows.&#160; Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations. </p> -5352452 1200000 <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>NOTE 4 &#150; PROPERTY AND EQUIPMENT</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>Property and equipment and related accumulated depreciation consisted of the following at September 30, 2018, and December 31, 2017:</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="428" style='border-collapse:collapse'> <tr style='height:38.25pt'> <td width="163" valign="bottom" style='width:122.1pt;padding:0;height:38.25pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> </td> <td width="115" valign="bottom" style='width:86.05pt;border:none;border-bottom:solid black 1.0pt;padding:0;height:38.25pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center'>September 30, 2018</p> </td> <td width="26" valign="bottom" style='width:19.85pt;border:none;border-bottom:solid black 1.0pt;padding:0;height:38.25pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center'>&nbsp;</p> </td> <td width="123" valign="bottom" style='width:92.0pt;border:none;border-bottom:solid black 1.0pt;padding:0;height:38.25pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center'>December 31, 2017</p> </td> <td width="1" valign="bottom" style='width:1.0pt;padding:0;height:38.25pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;margin-bottom:10.0pt;line-height:115%'><font style='line-height:115%'>&nbsp;</font></p> </td> </tr> <tr style='height:.2in'> <td width="163" valign="bottom" style='width:122.1pt;padding:0;height:.2in'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> </td> <td width="115" valign="bottom" style='width:86.05pt;padding:0;height:.2in'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&nbsp;</p> </td> <td width="26" valign="bottom" style='width:19.85pt;padding:0;height:.2in'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&nbsp;</p> </td> <td width="123" valign="bottom" style='width:92.0pt;padding:0;height:.2in'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&nbsp;</p> </td> <td width="1" valign="bottom" style='width:1.0pt;padding:0;height:.2in'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;margin-bottom:10.0pt;line-height:115%'>&nbsp;</p> </td> </tr> <tr style='height:.55in'> <td width="163" valign="bottom" style='width:122.1pt;padding:0;height:.55in'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>Equipment</p> </td> <td width="115" valign="bottom" style='width:86.05pt;padding:0;height:.55in'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;90,368</p> </td> <td width="26" valign="bottom" style='width:19.85pt;padding:0;height:.55in'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&nbsp;</p> </td> <td width="123" valign="bottom" style='width:92.0pt;padding:0;height:.55in'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 85,343</p> </td> <td width="1" valign="bottom" style='width:1.0pt;padding:0;height:.55in'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;margin-bottom:10.0pt;line-height:115%'>&nbsp;</p> </td> </tr> <tr style='height:63.0pt'> <td width="163" valign="bottom" style='width:122.1pt;padding:0;height:63.0pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>Accumulated depreciation</p> </td> <td width="115" valign="bottom" style='width:86.05pt;border:none;border-bottom:solid black 1.0pt;padding:0;height:63.0pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&#160;(49,803)</p> </td> <td width="26" valign="bottom" style='width:19.85pt;border:none;border-bottom:solid black 1.0pt;padding:0;height:63.0pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;margin-left:-4.5pt;text-align:right;text-indent:4.5pt'>&nbsp;</p> </td> <td width="123" valign="bottom" style='width:92.0pt;border:none;border-bottom:solid black 1.0pt;padding:0;height:63.0pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;margin-left:-4.5pt;text-align:right;text-indent:4.5pt'>&#160;(38,834)</p> </td> <td width="1" valign="bottom" style='width:1.0pt;padding:0;height:63.0pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;margin-bottom:10.0pt;line-height:115%'>&nbsp;</p> </td> </tr> <tr style='height:.2in'> <td width="163" valign="bottom" style='width:122.1pt;padding:0;height:.2in'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> </td> <td width="115" valign="bottom" style='width:86.05pt;padding:0;height:.2in'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&nbsp;</p> </td> <td width="26" valign="bottom" style='width:19.85pt;padding:0;height:.2in'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&nbsp;</p> </td> <td width="123" valign="bottom" style='width:92.0pt;padding:0;height:.2in'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&nbsp;</p> </td> <td width="1" valign="bottom" style='width:1.0pt;padding:0;height:.2in'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;margin-bottom:10.0pt;line-height:115%'><font style='line-height:115%'>&nbsp;</font></p> </td> </tr> <tr style='height:48.6pt'> <td width="163" valign="bottom" style='width:122.1pt;padding:0;height:48.6pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>Total Fixed Assets</p> </td> <td width="115" valign="bottom" style='width:86.05pt;border:none;border-bottom:double black 2.25pt;padding:0;height:48.6pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 40,565</p> </td> <td width="26" valign="bottom" style='width:19.85pt;border:none;border-bottom:double black 2.25pt;padding:0;height:48.6pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&nbsp;</p> </td> <td width="123" valign="bottom" style='width:92.0pt;border:none;border-bottom:double black 2.25pt;padding:0;height:48.6pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 46,509</p> </td> <td width="1" valign="bottom" style='width:1.0pt;padding:0;height:48.6pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;margin-bottom:10.0pt;line-height:115%'>&nbsp;</p> </td> </tr> </table> </div> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>Depreciation expense for the nine months ended September 30, 2018 and 2017 was $10,969 and $8,958, respectively.</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="428" style='border-collapse:collapse'> <tr style='height:38.25pt'> <td width="163" valign="bottom" style='width:122.1pt;padding:0;height:38.25pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> </td> <td width="115" valign="bottom" style='width:86.05pt;border:none;border-bottom:solid black 1.0pt;padding:0;height:38.25pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center'>September 30, 2018</p> </td> <td width="26" valign="bottom" style='width:19.85pt;border:none;border-bottom:solid black 1.0pt;padding:0;height:38.25pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center'>&nbsp;</p> </td> <td width="123" valign="bottom" style='width:92.0pt;border:none;border-bottom:solid black 1.0pt;padding:0;height:38.25pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center'>December 31, 2017</p> </td> <td width="1" valign="bottom" style='width:1.0pt;padding:0;height:38.25pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;margin-bottom:10.0pt;line-height:115%'><font style='line-height:115%'>&nbsp;</font></p> </td> </tr> <tr style='height:.2in'> <td width="163" valign="bottom" style='width:122.1pt;padding:0;height:.2in'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> </td> <td width="115" valign="bottom" style='width:86.05pt;padding:0;height:.2in'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&nbsp;</p> </td> <td width="26" valign="bottom" style='width:19.85pt;padding:0;height:.2in'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&nbsp;</p> </td> <td width="123" valign="bottom" style='width:92.0pt;padding:0;height:.2in'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&nbsp;</p> </td> <td width="1" valign="bottom" style='width:1.0pt;padding:0;height:.2in'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;margin-bottom:10.0pt;line-height:115%'>&nbsp;</p> </td> </tr> <tr style='height:.55in'> <td width="163" valign="bottom" style='width:122.1pt;padding:0;height:.55in'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>Equipment</p> </td> <td width="115" valign="bottom" style='width:86.05pt;padding:0;height:.55in'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;90,368</p> </td> <td width="26" valign="bottom" style='width:19.85pt;padding:0;height:.55in'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&nbsp;</p> </td> <td width="123" valign="bottom" style='width:92.0pt;padding:0;height:.55in'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 85,343</p> </td> <td width="1" valign="bottom" style='width:1.0pt;padding:0;height:.55in'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;margin-bottom:10.0pt;line-height:115%'>&nbsp;</p> </td> </tr> <tr style='height:63.0pt'> <td width="163" valign="bottom" style='width:122.1pt;padding:0;height:63.0pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>Accumulated depreciation</p> </td> <td width="115" valign="bottom" style='width:86.05pt;border:none;border-bottom:solid black 1.0pt;padding:0;height:63.0pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&#160;(49,803)</p> </td> <td width="26" valign="bottom" style='width:19.85pt;border:none;border-bottom:solid black 1.0pt;padding:0;height:63.0pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;margin-left:-4.5pt;text-align:right;text-indent:4.5pt'>&nbsp;</p> </td> <td width="123" valign="bottom" style='width:92.0pt;border:none;border-bottom:solid black 1.0pt;padding:0;height:63.0pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;margin-left:-4.5pt;text-align:right;text-indent:4.5pt'>&#160;(38,834)</p> </td> <td width="1" valign="bottom" style='width:1.0pt;padding:0;height:63.0pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;margin-bottom:10.0pt;line-height:115%'>&nbsp;</p> </td> </tr> <tr style='height:.2in'> <td width="163" valign="bottom" style='width:122.1pt;padding:0;height:.2in'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> </td> <td width="115" valign="bottom" style='width:86.05pt;padding:0;height:.2in'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&nbsp;</p> </td> <td width="26" valign="bottom" style='width:19.85pt;padding:0;height:.2in'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&nbsp;</p> </td> <td width="123" valign="bottom" style='width:92.0pt;padding:0;height:.2in'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&nbsp;</p> </td> <td width="1" valign="bottom" style='width:1.0pt;padding:0;height:.2in'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;margin-bottom:10.0pt;line-height:115%'><font style='line-height:115%'>&nbsp;</font></p> </td> </tr> <tr style='height:48.6pt'> <td width="163" valign="bottom" style='width:122.1pt;padding:0;height:48.6pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>Total Fixed Assets</p> </td> <td width="115" valign="bottom" style='width:86.05pt;border:none;border-bottom:double black 2.25pt;padding:0;height:48.6pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 40,565</p> </td> <td width="26" valign="bottom" style='width:19.85pt;border:none;border-bottom:double black 2.25pt;padding:0;height:48.6pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&nbsp;</p> </td> <td width="123" valign="bottom" style='width:92.0pt;border:none;border-bottom:double black 2.25pt;padding:0;height:48.6pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:right'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 46,509</p> </td> <td width="1" valign="bottom" style='width:1.0pt;padding:0;height:48.6pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;margin-bottom:10.0pt;line-height:115%'>&nbsp;</p> </td> </tr> </table> </div> 90368 85343 -49803 -38834 40565 46509 10969 8958 <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>NOTE 5 - PREFERRED STOCK</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>On October 19, 2011, the Company filed Articles of Incorporation with the State of Utah so as to authorize 10,000,000 shares of preferred stock having a par value of $0.001 per share. No preferred shares are issued or outstanding at September 30, 2018. </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>NOTE 6 - COMMON STOCK</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'><u>Subscription Payable</u>:</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>As of September 30, 2018, the Company has a subscription payable of $789,175, for which they have the obligation to issue 3,152,950 shares of restricted common stock.&#160; </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'>In February 2017, the Company entered into a stock purchase agreement with a related party, significant shareholder and debt holder (the &#147;buyer&#148;), under which the buyer may purchase up to $700,000 in shares of common stock at $0.25 per share. We have received $693,605 under this agreement as of the close of the subscription window on February 1, 2018, and of the corresponding 2,774,420 shares subscribed there are 2,734,420 shares that have yet to be issued as of the date of this report.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>In September 2017, the Company entered into another stock purchase agreement with the buyer, under which the buyer may purchase up to $400,000 in shares of common stock at $0.25 per share.&#160; The agreement expired on August 30, 2018.&#160; As of September 30, 2018, we have received $103,070 under this agreement for 412,280 shares, which have not been issued as of the date of this report.&#160; (see also Note 9 for subsequent investment by this related party).&#160; </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'><u>Common Stock Issued to Officer</u>:</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>On February 14, 2018 the Company announced that the consulting agreement with the Chief Financial Officer (Mr. Merrell) was terminated effective December 31, 2017, and that a new agreement was entered into effective January 1, 2018 under which Mr. Merrell would receive 2,000,000 shares of restricted common stock, vesting at 500,000 shares per year, for his service.&#160; The term of the agreement is for one year, renewable for one year extensions up to four years.&#160; The Company issued all 2,000,000 shares to Mr. Merrell on August 20, 2018.&#160; Any common shares not earned during the four-year period are to be returned or cancelled.&#160; An expense of $150,000 was recorded for the nine-month period ended September 30, 2018, which represents the fair value of the stock vested during that reporting period.&#160; A charge will be made each quarter as the shares are earned under the provisions of the agreement until such time as all shares have been earned.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'><u>Common Stock Issued for Cash</u>:</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>In May 2018, the Company entered into three stock subscriptions agreements with two investors.&#160; The subscriptions gave the investors the right to purchase up to 440,000 shares of restricted common stock at $0.25 per share.&#160; The Company received $110,000 under these subscription agreements and issued the 440,000 shares of restricted stock in June to fully satisfy its obligations under the agreements.&#160;&#160;&#160; </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'><u>Common Stock Issued for Services</u>:</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>In September 2018, the Company issued 650,000 shares of stock to two consultants.&#160; Of the shares, 150,000 were issued under a consulting contract for services rendered and vested upon issue and 500,000 shares of restricted stock were issued to a consultant for services rendered and to be rendered through June 1, 2019.&#160; Consulting expenses amounting to $309,000 have been recorded during the nine-month period ended September 30, 2018.&#160; A prepaid expense of $330,000 is recorded and will be amortized over the term of the consulting agreement.</p> 10000000 0.001 789175 3152950 700000 0.25 693605 2774420 2734420 103070 412280 2000000 500000 150000 440000 0.25 110000 650000 150000 500000 309000 330000 <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>NOTE 7 &#150; CONVERTIBLE PROMISSORY NOTES</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'><i>$100,000 Convertible Promissory Note</i></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>On November 12, 2012, the Company issued a $100,000 convertible promissory note to SCS, a related party and significant shareholder, as compensation for services provided and to be provided during the period April 1, 2012 through March 31, 2013.&#160; The note is due on demand, bears annual interest at 5.5%, and is convertible into shares of common stock at a conversion price to be agreed upon immediately prior to conversion.&#160; On September 27, 2013, the Company amended the note to include a conversion price which of $0.01 per share for all unpaid principal and interest.&#160; As of September 30, 2018 and December 31, 2017 interest accrued, but unpaid, was $35,762 and $31,629, respectively.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'><i>$130,100 Convertible Promissory Note</i></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>Prior to 2015, the Company entered into a convertible promissory note with SCS, a related party and significant shareholder, due on demand, bearing interest at 8% per annum, unsecured and convertible at $0.01 per share, with a price protection provision to a lower conversion price.&#160; The balance of this note was $130,100 at September 30, 2018 and December 31, 2017 with accrued interest balances of $57,774 and $49,953, respectively.</p> 100000 0.0550 0.01 35762 31629 0.0800 0.01 130100 57774 49953 <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>NOTE 8 - COMMITMENTS AND CONTINGENCIES</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'><u>Operating Lease Obligations</u></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>The Company entered into a lease for office space in February 2017 for $950 per month.&#160; In November 2017 the Company signed a six-month extension of the lease with a lease payment of $978 per month. In July 2018 the Company signed a one-year extension to the lease with a monthly lease payment of $1,008.&#160; Obligations under this lease are as follows:</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'><font style='display:none'>&#160;</font></p> <table border="0" cellspacing="0" cellpadding="0" width="573" style='width:430.0pt;margin-left:4.65pt;border-collapse:collapse'> <tr style='height:15.0pt'> <td width="320" valign="bottom" style='width:240.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="80" valign="bottom" style='width:60.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>&#160;&#160;&#160; 2018</p> </td> <td width="83" valign="bottom" style='width:62.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>&#160;&#160;&#160; 2019</p> </td> <td width="91" valign="bottom" style='width:68.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>&#160;&#160;&#160; 2020</p> </td> </tr> <tr style='height:15.0pt'> <td width="320" valign="bottom" style='width:240.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'>Office lease</p> </td> <td width="80" valign="bottom" style='width:60.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>&#160; $&#160;&#160;&#160; 3,024 </p> </td> <td width="83" valign="bottom" style='width:62.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 8,063&#160;&#160; </p> </td> <td width="91" valign="bottom" style='width:68.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -&#160;&#160; </p> </td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>In 2017 the Company entered into a 24-month lease for a nitric oxide analyzer, with a monthly payment of $1,014 per month.&#160; </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>Obligations under the equipment lease are as follows:</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="573" style='width:430.0pt;margin-left:4.65pt;border-collapse:collapse'> <tr style='height:15.0pt'> <td width="320" valign="bottom" style='width:240.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="80" valign="bottom" style='width:60.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>2018</p> </td> <td width="83" valign="bottom" style='width:62.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>2019</p> </td> <td width="91" valign="bottom" style='width:68.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>2020</p> </td> </tr> <tr style='height:15.0pt'> <td width="320" valign="bottom" style='width:240.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'>Equipment lease</p> </td> <td width="80" valign="bottom" style='width:60.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>&#160;$&#160;&#160;&#160; 3,042 </p> </td> <td width="83" valign="bottom" style='width:62.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>12,167</p> </td> <td width="91" valign="bottom" style='width:68.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -&#160;&#160; </p> </td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>The lease is a capital lease, with the option to purchase at the end of the lease term.&#160; The Company plans to exercise the purchase option under the lease, whereby 70% of the lease payments will be applied toward the purchase price of the equipment. </p> 950 978 1008 <table border="0" cellspacing="0" cellpadding="0" width="573" style='width:430.0pt;margin-left:4.65pt;border-collapse:collapse'> <tr style='height:15.0pt'> <td width="320" valign="bottom" style='width:240.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="80" valign="bottom" style='width:60.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>&#160;&#160;&#160; 2018</p> </td> <td width="83" valign="bottom" style='width:62.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>&#160;&#160;&#160; 2019</p> </td> <td width="91" valign="bottom" style='width:68.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>&#160;&#160;&#160; 2020</p> </td> </tr> <tr style='height:15.0pt'> <td width="320" valign="bottom" style='width:240.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'>Office lease</p> </td> <td width="80" valign="bottom" style='width:60.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>&#160; $&#160;&#160;&#160; 3,024 </p> </td> <td width="83" valign="bottom" style='width:62.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 8,063&#160;&#160; </p> </td> <td width="91" valign="bottom" style='width:68.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -&#160;&#160; </p> </td> </tr> </table> 3024 8063 1014 <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="573" style='width:430.0pt;margin-left:4.65pt;border-collapse:collapse'> <tr style='height:15.0pt'> <td width="320" valign="bottom" style='width:240.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="80" valign="bottom" style='width:60.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>2018</p> </td> <td width="83" valign="bottom" style='width:62.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>2019</p> </td> <td width="91" valign="bottom" style='width:68.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>2020</p> </td> </tr> <tr style='height:15.0pt'> <td width="320" valign="bottom" style='width:240.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-autospace:ideograph-numeric ideograph-other'>Equipment lease</p> </td> <td width="80" valign="bottom" style='width:60.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>&#160;$&#160;&#160;&#160; 3,042 </p> </td> <td width="83" valign="bottom" style='width:62.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>12,167</p> </td> <td width="91" valign="bottom" style='width:68.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:center;text-autospace:ideograph-numeric ideograph-other'>$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -&#160;&#160; </p> </td> </tr> </table> 3042 12167 <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify;background:white'>NOTE 9 - SUBSEQUENT EVENTS</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>On October 18, 2018 the company agreed to amend the stock purchase agreement entered into in September 2017 with the buyer, under which the buyer may purchase up to $400,000 in shares of common stock at $0.25 per share (see Note 6).&#160; The agreement had an expiration date of August 30, 2018.&#160; Upon agreeing to extend the expiration date to August 30, 2019, the Company accepted $25,000 under that agreement, under which the buyer may purchase up to $400,000 in shares of common stock at $0.25 per share.&#160; A total of $128,070 has been received under this agreement, and there are 512,280 shares of restricted common stock that will be issued in satisfaction of the Company&#146;s obligation under those agreements.&#160; </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>On October 24, 2018 the Company entered into stock subscription agreements with two individuals under which they may purchase up to $35,000 in shares of common stock at $0.25 per share.&#160; The Company accepted $35,000 under those agreements on October 24, 2018, and there are 140,000 shares of restricted common stock that will be issued in satisfaction of the Company&#146;s obligation under those agreements.&#160; </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none;text-align:justify'>The Company has evaluated subsequent events pursuant to ASC Topic 855 and has determined that there are no events that require disclosure as of the date of issuance.</p> 400000 0.25 25000 128070 512280 0.25 35000 140000 0001543637 2018-01-01 2018-09-30 0001543637 2018-09-30 0001543637 2018-11-19 0001543637 2018-11-14 2018-11-14 0001543637 2017-12-31 0001543637 2018-07-01 2018-09-30 0001543637 2017-07-01 2017-09-30 0001543637 2017-01-01 2017-09-30 0001543637 2016-12-31 0001543637 2017-09-30 0001543637 2017-02-01 2017-02-28 0001543637 2018-02-01 2018-02-28 0001543637 2017-09-02 0001543637 2017-09-02 2017-09-02 0001543637 2018-05-02 0001543637 2018-09-01 2018-09-30 0001543637 2012-11-12 0001543637 2017-11-01 2018-05-31 0001543637 2018-07-01 2019-06-30 0001543637 2018-10-01 2018-10-31 0001543637 2018-10-24 xbrli:pure iso4217:USD xbrli:shares iso4217:USD xbrli:shares EX-101.SCH 7 numd-20180930.xsd XBRL TAXONOMY EXTENISON SCHEMA DOCUMENT 000030 - Statement - Condensed Balance Sheets - Parenthetical link:presentationLink link:definitionLink link:calculationLink 000170 - Disclosure - Preferred and Common Stock (Details) link:presentationLink link:definitionLink link:calculationLink 000120 - Disclosure - Organization and Description of Business (Policies) link:presentationLink link:definitionLink link:calculationLink 000180 - Disclosure - Convertible Notes and Derivative Liability (Details) link:presentationLink link:definitionLink link:calculationLink 000150 - Disclosure - Organization and Description of Business (Details) link:presentationLink link:definitionLink link:calculationLink 000090 - Disclosure - Convertible Notes and Derivative Liability link:presentationLink link:definitionLink link:calculationLink 000130 - Disclosure - Property and Equipment (Tables) link:presentationLink link:definitionLink link:calculationLink 000100 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 000050 - Statement - Condensed Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 000190 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 000160 - Disclosure - Property and Equipment (Details) link:presentationLink link:definitionLink link:calculationLink 000010 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 000060 - Disclosure - Organization and Description of Business link:presentationLink link:definitionLink link:calculationLink 000020 - Statement - Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 000070 - Disclosure - Property and Equipment link:presentationLink link:definitionLink link:calculationLink 000080 - Disclosure - Preferred and Common Stock link:presentationLink link:definitionLink link:calculationLink 000040 - Statement - Condensed Statements of Operations link:presentationLink link:definitionLink link:calculationLink 000140 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 000110 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 000200 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 numd-20180930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 numd-20180930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 numd-20180930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Additional Subscription Under $400,000 Stock Purchase Agreement Additional Subscription Under $400,000 Stock Purchase Agreement 130,100 convertible promissory note interest rate 130,100 convertible promissory note interest rate Total stock subscription shares Total stock subscription shares Cash paid for interest Net cash used in investing activities Long-term assets Entity Listing, Par Value Per Share Emerging Growth Company Public Float 130,100 convertible promissory note principal balace 130,100 convertible promissory note principal balace 110,000 Stock Subscription Amount 400,000 Stock Subscription Amount Common Stock, Share Subscribed but Unissued, Subscriptions Receivable Earnings Per Share Subsequent Events Supplemental schedule of non-cash financing activities Stock issued for services performed Document Fiscal Period Focus Other Commitments, Future Minimum Payments, Remainder of Fiscal Year Common Stock, Shares Subscribed but Unissued Estimates Commitments and Contingencies {1} Commitments and Contingencies Interest expense Operating Loss Cash Entity Incorporation, State Country Name Voluntary filer SCS convertible promissory note interest rate SCS convertible promissory note interest rate Organization and Description of Business Adjustment to reconcile net income (loss) to net cash used in operating activities: Total other income/expense General and administrative expense Accrued Expense Accounts payable - related party Prepaid expense Stock Issued During Period, Shares, Period Increase (Decrease) Schedule of Future Minimum Lease Payments for Capital Leases Income Taxes Cash and Cash Equivalents Preferred and Common Stock Net cash used in operating activities Decrease in related party payables Cash flows from operating activities: Gain on extinguishment of debt Gain on debt extinguishment Common Stock, Par or Stated Value Per Share Consulting stock compensation 1 Represents the Consulting stock compensation 1 (number of shares), during the indicated time period. Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Property and equipment Convertible Notes and Derivative Liability Common stock issued to settle subscription payable Cash flows from financing activities Net income (loss) Net income (loss) Total operating expenses Total current liabilities Total assets Total assets Total long-term assets Ex Transition Period Registrant Name Other Commitment, Due in Second Year Capital Leases, Future Minimum Payments Due SCS convertible promissory note conversion price SCS convertible promissory note conversion price Net cash provided by financing activities Cash flows from investing activities: Revenue Preferred Stock, Shares Issued Stock subscription payable Stock subscription payable Accounts payable Current assets Amendment Description Fiscal Year End Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price Property, Plant and Equipment Purchase of equipment Rent expense Common Stock, Shares, Outstanding Property and equipment, net Current with reporting Merrell stock compensation Represents the Merrell stock compensation (number of shares), during the indicated time period. Notes Net increase (decrease) in cash Net increase (decrease) in cash (Decrease) increase in accounts payable Loss on derivative liability Loss on derivative Total stockholders' equity (deficit) Stockholders' equity (deficit) Commitments and contingencies Equipment loan - current portion LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) 130,100 convertible promissory note accrued interest 130,100 convertible promissory note accrued interest Stock Issued During Period, Value, New Issues Tables/Schedules Accounting Method Equipment loan Common Stock, Shares Authorized Consulting stock compensation 2 Represents the Consulting stock compensation 2 (number of shares), during the indicated time period. 400,000 Stock Subscription Amount 400,000 Stock Subscription Amount Planned expenditures Represents the monetary amount of Planned expenditures, during the indicated time period. Diluted income (loss) per share Other income/expense Professional and consulting fees Preferred Stock, Shares Outstanding Accumulated deficit Accumulated deficit Common stock; $0.001 par value; 90,000,000 authorized; 40,934,375 and 37,563,125 shares issued and outstanding, as of September 30, 2018 and December 31, 2017, respectively. Convertible Promissory Notes - Related party Small Business Period End date SEC Form Registrant CIK Accumulated Depreciation Represents the monetary amount of Accumulated Depreciation, as of the indicated date. Property, Plant and Equipment, Gross Convertible Notes Dilutive Shares Convertible Notes Dilutive Shares Proceeds from stock subscriptions payable Amendment Flag 140,000 Stock Subscription Amount 140,000 Stock Subscription Amount 110,000 Stock Subscription Shares 400,000 Stock Subscription Shares New Accounting Pronouncements Fair Value Revenue Recognition Policies Increase (decrease) in accrued expense (Increase) decrease in prepaid expenses Payroll expense Operating expenses Long-term liabilities Current liabilities Shell Company Filer Category 140,000 Stock Subscription Shares 140,000 Stock Subscription Shares monthly equipment lease payment monthly equipment lease payment Other Prepaid Expense, Current Services Rendered for Subscription Receivable Represents the monetary amount of Services Rendered for Subscription Receivable, during the indicated time period. Equity Instruments Issued For Non-cash Items Reclassification of operating expenses Common stock issued for prepaid services Payments on equipment loan Proceeds from issuance of common stock Basic income (loss) per share Preferred Stock, Shares Authorized Total liabilities and stockholders' equity (deficit) Total liabilities and stockholders' equity (deficit) Additional paid-in capital Total liabilities Equipment loan - long-term portion ASSETS Document Fiscal Year Focus Number of common stock shares outstanding monthly office lease payment Represents the monetary amount of monthly office lease payment, during the indicated time period. Supplemental schedule of cash flow information Payments on convertible notes payable Weighted average common shares outstanding - diluted Weighted average common shares outstanding - basic Amortization of debt discount Amortization of debt discount Well-known Seasoned Issuer Capital Leases, Future Minimum Payments Due in Two Years 130,100 convertible promissory note conversion price 130,100 convertible promissory note conversion price 400,000 Amount Used From Subscription 400,000 Amount Used From Subscription Cash paid for income tax Stock-based compensation Depreciation and amortization Income tax expense Common Stock, Shares, Issued Total current assets Tax Identification Number (TIN) SCS convertible promissory note principal SCS convertible promissory note principal Remaining Shares Under $400,000 Stock Purchase Agreement Remaining Shares Under $400,000 Stock Purchase Agreement Outstanding common stock equivalents Outstanding common stock equivalents Equipment lease Property and Equipment Cash at beginning of period Cash at beginning of period Cash at end of period Depreciation expense Preferred Stock, Par or Stated Value Per Share Preferred stock; $0.001 par value; 10,000,000 authorized; no shares issued and outstanding, respectively. Trading Symbol Details XML 11 R1.htm IDEA: XBRL DOCUMENT v3.10.0.1
Document and Entity Information - $ / shares
9 Months Ended
Nov. 14, 2018
Sep. 30, 2018
Nov. 19, 2018
Details      
Registrant Name   Nu-Med Plus, Inc.  
Registrant CIK   0001543637  
SEC Form   10-Q  
Period End date   Sep. 30, 2018  
Fiscal Year End   --12-31  
Trading Symbol   NUMD  
Tax Identification Number (TIN)   453672530  
Number of common stock shares outstanding     40,934,375
Filer Category   Non-accelerated Filer  
Current with reporting   Yes  
Small Business   true  
Emerging Growth Company   true  
Ex Transition Period   false  
Amendment Flag   false  
Document Fiscal Year Focus   2018  
Document Fiscal Period Focus   Q3  
Entity Incorporation, State Country Name   Utah  
Entity Listing, Par Value Per Share $ 0.001    
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Balance Sheets - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Current assets    
Cash $ 168,262 $ 351,043
Prepaid expense 343,624 9,167
Total current assets 511,886 360,210
Long-term assets    
Property and equipment, net 40,565 46,509
Total long-term assets 40,565 46,509
Total assets 552,451 406,719
Current liabilities    
Accounts payable 11,430 0
Accounts payable - related party 6,547 4,000
Accrued Expense 96,511 84,411
Equipment loan - current portion 9,399 9,399
Convertible Promissory Notes - Related party 230,100 230,100
Total current liabilities 353,987 327,910
Long-term liabilities    
Equipment loan - long-term portion 3,980 10,567
Total liabilities 357,967 338,477
Commitments and contingencies 0 0
Stockholders' equity (deficit)    
Preferred stock; $0.001 par value; 10,000,000 authorized; no shares issued and outstanding, respectively. 0 0
Common stock; $0.001 par value; 90,000,000 authorized; 40,934,375 and 37,563,125 shares issued and outstanding, as of September 30, 2018 and December 31, 2017, respectively. 40,934 37,564
Additional paid-in capital 4,716,827 3,728,836
Stock subscription payable 789,175 806,405
Accumulated deficit (5,352,452) (4,504,563)
Total stockholders' equity (deficit) 194,484 68,242
Total liabilities and stockholders' equity (deficit) $ 552,451 $ 406,719
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Balance Sheets - Parenthetical - $ / shares
Sep. 30, 2018
Dec. 31, 2017
Details    
Preferred Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Preferred Stock, Shares Authorized 10,000,000 10,000,000
Preferred Stock, Shares Issued 0 0
Preferred Stock, Shares Outstanding 0 0
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Common Stock, Shares Authorized 90,000,000 90,000,000
Common Stock, Shares, Issued 40,934,375 37,563,125
Common Stock, Shares, Outstanding 40,934,375 37,563,125
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Details        
Revenue $ 0 $ 0 $ 0 $ 0
Operating expenses        
General and administrative expense 40,064 31,831 87,191 49,293
Payroll expense 59,266 11,527 184,716 34,099
Rent expense 4,540 4,287 13,504 12,416
Professional and consulting fees 414,618 86,518 536,965 214,012
Depreciation expense 3,581 3,586 10,969 8,958
Total operating expenses 522,069 137,749 833,345 318,778
Operating Loss (522,069) (137,749) (833,345) (318,778)
Other income/expense        
Interest expense (4,779) (5,228) (14,544) (13,880)
Amortization of debt discount 0 0 0 (21,508)
Gain on extinguishment of debt 0 0 0 6,716,358
Loss on derivative 0 0 0 (2,632,571)
Total other income/expense (4,779) (5,228) (14,544) 4,048,399
Income tax expense 0 0 0 0
Net income (loss) $ (526,848) $ (142,977) $ (847,889) $ 3,729,621
Basic income (loss) per share $ (0.01) $ (0.00) $ (0.02) $ 0.10
Weighted average common shares outstanding - basic 39,043,668 37,322,711 38,187,449 37,322,415
Diluted income (loss) per share $ (0.01) $ (0.00) $ (0.02) $ 0.05
Weighted average common shares outstanding - diluted 39,043,668 37,322,711 38,187,449 76,399,015
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net income (loss) $ (847,889) $ 3,729,621
Adjustment to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 10,970 8,958
Gain on debt extinguishment 0 (6,716,358)
Stock-based compensation 182,061 0
Stock issued for services performed 309,000 24,949
Amortization of debt discount 0 21,508
Loss on derivative liability 0 2,632,571
(Increase) decrease in prepaid expenses (4,457) 0
(Decrease) increase in accounts payable 11,430 (5,065)
Decrease in related party payables 2,547 (2,000)
Increase (decrease) in accrued expense 12,100 14,486
Net cash used in operating activities (324,238) (291,330)
Cash flows from investing activities:    
Purchase of equipment (5,026) 0
Net cash used in investing activities (5,026) 0
Cash flows from financing activities    
Proceeds from stock subscriptions payable 43,070 0
Proceeds from issuance of common stock 110,000 729,705
Payments on equipment loan (6,587) (14,012)
Payments on convertible notes payable 0 (27,500)
Net cash provided by financing activities 146,483 688,193
Net increase (decrease) in cash (182,781) 396,863
Cash at beginning of period 351,043 12,450
Cash at end of period 168,262 409,313
Supplemental schedule of cash flow information    
Cash paid for interest 2,488 1,962
Cash paid for income tax 100 0
Supplemental schedule of non-cash financing activities    
Equipment loan 0 35,970
Common stock issued to settle subscription payable 60,300 0
Common stock issued for prepaid services $ 495,000 $ 0
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization and Description of Business
9 Months Ended
Sep. 30, 2018
Notes  
Organization and Description of Business

 

NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Nu-Med Plus, Inc. is an emerging growth early stage medical device company principally engaged in the design, innovation, development, enhancement and commercialization of beginning, early, and selective later-stage quality medical devices. The Company's immediate focus is on a nitric oxide powder formulation that is 99% pure-with a one year shelf life, a "hospital" generator device with controls, plus built-in safety monitors, that delivers inhaled nitric oxide to replace expensive pressurized canisters, a compact mobile rechargeable device to deliver inhaled nitric oxide gas and a nitric oxide clinical unit, along with research into the application of nitric oxide in wound healing. The Company is incorporated in Utah.

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

a. Basis of Interim Financial Statement Presentation

 

The accompanying unaudited financial statements have been prepared by the Company pursuant to accounting principles generally accepted in the United States of America.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with rules and regulations of the Securities and Exchange Commission.  The information furnished in the interim financial statements includes normal recurring adjustments and reflects all adjustments which, in the opinion of management, are necessary for a fair presentation of such financial statements.  Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim financial statements be read in conjunction with the Company’s most recent audited financial statements and notes thereto included in its December 31, 2017 financial statements.  Operating results for the three and nine months ended September 30, 2018 are not necessarily indicative of the results that may be expected for the year ending December 31, 2018.

b. Reclassification of operating expenses

 

The Company has made a reclassification of the 2017 operating expenses that affects general and administrative expense and professional and consulting fees.  In the previously published 2017 financial statement presentations legal fees were included in general and administrative expenses.  In these accompanying unaudited financial statements those legal expenses have been reclassified to professional and consulting fees for comparative purposes, as in the 2018 financial presentation legal fees are included in the professional and consulting fee operating expenses.

 

c. Revenue Recognition

 

The Company is currently developing its products. It is anticipated that revenue will be recognized on product sales once the product has been shipped to the customers, persuasive evidence of an agreement exists, the price is fixed or determinable, and collectability is reasonably assured.

 

d. Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

 

 

e. Fair Value

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  FASB Accounting Standards Codification (“ASC”) Topic 820 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 

Level 1 - Quoted market prices in active markets for identical assets or liabilities;

 

Level 2 - Inputs other than level one inputs that are either directly or indirectly observable; and

 

Level 3 - Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

 

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is observable.

 

All cash, accounts receivable, accounts payable and accrued liabilities are carried at cost, which approximates fair value due to the short-term nature of these financial instruments.  Additionally, we measure certain financial instruments at fair value on a recurring basis.

 

f. Cash and Cash Equivalents

 

The Company considers all deposit accounts and investment accounts with an original maturity of 90 days or less to be cash equivalents.  

 

g. Property and Equipment

 

Property and equipment items are stated at cost.  Expenditure for minor repairs, maintenance, and replacement parts which do not increase the useful lives of the assets are charged to expense as incurred. Expenditures exceeding $500 for new assets, or that increase the useful life of existing assets, are capitalized.  Depreciation is computed using the straight-line method.  The lives over which the property and equipment is depreciated are five to seven years.

 

h. Earnings per Share

 

The computation of earnings per share of common stock is based on the weighted average number of shares outstanding during the period of the financial statement as follows:

 

Diluted earnings per share is computed using the weighted average number of common shares plus dilutive common share equivalents outstanding during the period.  For the three months ended September 30, 2018 and September 30, 2017 there were no common stock equivalents from outstanding convertible notes included in the calculation.  For the nine months ended September 30, 2018 and September 30, 2017 there were 0 and 39,076,600 common stock equivalents from outstanding notes included in the calculation.  As of September 30, 2018 there were 32,294,231 potentially dilutive shares related to convertible notes and 3,152,950 potentially dilutive shares related to subscription payables that needed to be considered as common stock equivalents.  The common stock equivalents were excluded from the calculation of diluted earnings per share because the effect these common stock equivalents would have been anti-dilutive as of September 30, 2018.

 

Earnings per share are shown, both basic and diluted, on the statement of operations.

 

i. Income Taxes

 

Deferred taxes are provided on an asset and liability approach whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

j. Equity Instruments Issued for Non-Cash Items

 

In accordance with ASC Topic 718, the Company records equity instruments issued for non-cash items at the grant-date fair value of the equity instruments issued.

 

k. Recent Accounting Pronouncements

 

reduced the U.S. federal corporate tax rate from 35% to 21% effective January 1, 2018.  Also, on December 22, 2017, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 118 (“SAB 118”), which provides guidance on accounting for tax effects of the Tax Act.  SAB 118 provides a measurement period of up to one year from the enactment date to complete the accounting.  Any adjustments during this measurement period will be included in net earnings from continuing operations as an adjustment to income tax expense in the reporting period when such adjustments are determined.  As the Company has net operating loss carryforwards which will offset tax liability for the coming year or years, no adjustments for the effect of the income tax rate change is reflected in our financial statements.

 

In February 2018, the Financial Standards Accounting Board (“FASB”) issued Accounting Statement Update No. 2018-02, “Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.”  This ASU allows a reclassification from accumulated other comprehensive income (“AOCI”) to retained earnings for certain income tax effects stranded in AOCI as a result of the Tax Act.  The reclassification eliminates the stranded tax effects resulting from the Tax Act and is intended to improve the usefulness of information reported to financial statement users.  ASU No. 2018-02 is effective for reporting periods beginning on January 1, 2019; early adoption is permitted. The Company does not currently have amounts to be reclassified under this and therefore believes it will not have an impact on its financial statements and statements of operations.

 

In June 2018, the FASB issued ASU No. 2018-07, “Compensation — Stock Compensation (Topic 718),” (“ASU 2018-07”). ASU 2018-07 is intended to reduce cost and complexity of financial reporting for non-employee share-based payments. Currently, the accounting requirements for non-employee and employee share-based payments are significantly different. ASU 2018-07 expands the scope of Topic 718, which currently only includes share-based payments to employees, to include share-based payments to non-employees for goods or services. Consequently, the accounting for share-based payments to non-employees and employees will be substantially aligned. This ASU supersedes Subtopic 505-50, “Equity — Equity-Based Payments to Nonemployees”. The amendments to ASU 2018 - 07 are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than a company’s adoption date of ASU No. 2014-09, (Topic 606), “Revenue from Contracts with Customers”. The Company is currently evaluating ASU 2018-07 and its impact on its condensed consolidated financial statements or disclosures.

 

In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders' equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders' equity presented in the balance sheet must be provided in a note or separate statement. The analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. This final rule is effective on November 5, 2018. The Company is in the process of evaluating the impact of the final rule on its consolidated financial statements.

 

The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows.  Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.

 

NOTE 3 - GOING CONCERN

 

The Company continues to accumulate significant operating losses and has an accumulated deficit of $5,352,452 at September 30, 2018.  The funds on hand as of September 30, 2018, will not be sufficient to enable it to execute its business plan and funding through the sale of equity capital and short term related party and other shareholder loans in order to meet the planned expenditures for development, operations, and administrative cost over the next 12 months will be required. Planned expenditures are approximately $1,200,000 for the next twelve months. If plans to obtain further financing prove to be insufficient to fund operations, continued viability could be at risk.  These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance of these financial statements.  The financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

The Company acknowledges that the funds on hand as of September 30, 2018, will not be sufficient to enable it to execute its business plan and funding through the sale of equity capital and short term related party and other shareholder loans in order to meet the planned expenditures for development, operations, and administrative cost over the next 12 months will be required. Planned expenditures are approximately $1,200,000 for the next twelve months. The Company is currently funded through December 31, 2018. If plans to obtain further financing prove to be insufficient to fund operations, continued viability could be at risk.

XML 17 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property and Equipment
9 Months Ended
Sep. 30, 2018
Notes  
Property and Equipment

 

NOTE 4 – PROPERTY AND EQUIPMENT

 

Property and equipment and related accumulated depreciation consisted of the following at September 30, 2018, and December 31, 2017:

 

September 30, 2018

 

December 31, 2017

 

 

 

 

 

 

Equipment

$                   90,368

 

$                      85,343

 

Accumulated depreciation

 (49,803)

 

 (38,834)

 

 

 

 

 

 

Total Fixed Assets

$                    40,565

 

                      46,509

 

 

Depreciation expense for the nine months ended September 30, 2018 and 2017 was $10,969 and $8,958, respectively.

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Preferred and Common Stock
9 Months Ended
Sep. 30, 2018
Notes  
Preferred and Common Stock

 

NOTE 5 - PREFERRED STOCK

 

On October 19, 2011, the Company filed Articles of Incorporation with the State of Utah so as to authorize 10,000,000 shares of preferred stock having a par value of $0.001 per share. No preferred shares are issued or outstanding at September 30, 2018.

 

NOTE 6 - COMMON STOCK

 

Subscription Payable:

 

As of September 30, 2018, the Company has a subscription payable of $789,175, for which they have the obligation to issue 3,152,950 shares of restricted common stock. 

 

In February 2017, the Company entered into a stock purchase agreement with a related party, significant shareholder and debt holder (the “buyer”), under which the buyer may purchase up to $700,000 in shares of common stock at $0.25 per share. We have received $693,605 under this agreement as of the close of the subscription window on February 1, 2018, and of the corresponding 2,774,420 shares subscribed there are 2,734,420 shares that have yet to be issued as of the date of this report.

 

In September 2017, the Company entered into another stock purchase agreement with the buyer, under which the buyer may purchase up to $400,000 in shares of common stock at $0.25 per share.  The agreement expired on August 30, 2018.  As of September 30, 2018, we have received $103,070 under this agreement for 412,280 shares, which have not been issued as of the date of this report.  (see also Note 9 for subsequent investment by this related party). 

 

Common Stock Issued to Officer:

 

On February 14, 2018 the Company announced that the consulting agreement with the Chief Financial Officer (Mr. Merrell) was terminated effective December 31, 2017, and that a new agreement was entered into effective January 1, 2018 under which Mr. Merrell would receive 2,000,000 shares of restricted common stock, vesting at 500,000 shares per year, for his service.  The term of the agreement is for one year, renewable for one year extensions up to four years.  The Company issued all 2,000,000 shares to Mr. Merrell on August 20, 2018.  Any common shares not earned during the four-year period are to be returned or cancelled.  An expense of $150,000 was recorded for the nine-month period ended September 30, 2018, which represents the fair value of the stock vested during that reporting period.  A charge will be made each quarter as the shares are earned under the provisions of the agreement until such time as all shares have been earned.

 

Common Stock Issued for Cash:

 

In May 2018, the Company entered into three stock subscriptions agreements with two investors.  The subscriptions gave the investors the right to purchase up to 440,000 shares of restricted common stock at $0.25 per share.  The Company received $110,000 under these subscription agreements and issued the 440,000 shares of restricted stock in June to fully satisfy its obligations under the agreements.   

 

Common Stock Issued for Services:

 

In September 2018, the Company issued 650,000 shares of stock to two consultants.  Of the shares, 150,000 were issued under a consulting contract for services rendered and vested upon issue and 500,000 shares of restricted stock were issued to a consultant for services rendered and to be rendered through June 1, 2019.  Consulting expenses amounting to $309,000 have been recorded during the nine-month period ended September 30, 2018.  A prepaid expense of $330,000 is recorded and will be amortized over the term of the consulting agreement.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Convertible Notes and Derivative Liability
9 Months Ended
Sep. 30, 2018
Notes  
Convertible Notes and Derivative Liability

 

NOTE 7 – CONVERTIBLE PROMISSORY NOTES

 

 

$100,000 Convertible Promissory Note

On November 12, 2012, the Company issued a $100,000 convertible promissory note to SCS, a related party and significant shareholder, as compensation for services provided and to be provided during the period April 1, 2012 through March 31, 2013.  The note is due on demand, bears annual interest at 5.5%, and is convertible into shares of common stock at a conversion price to be agreed upon immediately prior to conversion.  On September 27, 2013, the Company amended the note to include a conversion price which of $0.01 per share for all unpaid principal and interest.  As of September 30, 2018 and December 31, 2017 interest accrued, but unpaid, was $35,762 and $31,629, respectively.

 

$130,100 Convertible Promissory Note

Prior to 2015, the Company entered into a convertible promissory note with SCS, a related party and significant shareholder, due on demand, bearing interest at 8% per annum, unsecured and convertible at $0.01 per share, with a price protection provision to a lower conversion price.  The balance of this note was $130,100 at September 30, 2018 and December 31, 2017 with accrued interest balances of $57,774 and $49,953, respectively.

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies
9 Months Ended
Sep. 30, 2018
Notes  
Commitments and Contingencies

 

NOTE 8 - COMMITMENTS AND CONTINGENCIES

 

Operating Lease Obligations

 

The Company entered into a lease for office space in February 2017 for $950 per month.  In November 2017 the Company signed a six-month extension of the lease with a lease payment of $978 per month. In July 2018 the Company signed a one-year extension to the lease with a monthly lease payment of $1,008.  Obligations under this lease are as follows:

 

 

    2018

    2019

    2020

Office lease

  $    3,024

$         8,063  

$                   -  

 

In 2017 the Company entered into a 24-month lease for a nitric oxide analyzer, with a monthly payment of $1,014 per month. 

 

Obligations under the equipment lease are as follows:

 

 

2018

2019

2020

Equipment lease

 $    3,042

12,167

$                   -  

 

The lease is a capital lease, with the option to purchase at the end of the lease term.  The Company plans to exercise the purchase option under the lease, whereby 70% of the lease payments will be applied toward the purchase price of the equipment.

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events
9 Months Ended
Sep. 30, 2018
Notes  
Subsequent Events

 

NOTE 9 - SUBSEQUENT EVENTS

 

On October 18, 2018 the company agreed to amend the stock purchase agreement entered into in September 2017 with the buyer, under which the buyer may purchase up to $400,000 in shares of common stock at $0.25 per share (see Note 6).  The agreement had an expiration date of August 30, 2018.  Upon agreeing to extend the expiration date to August 30, 2019, the Company accepted $25,000 under that agreement, under which the buyer may purchase up to $400,000 in shares of common stock at $0.25 per share.  A total of $128,070 has been received under this agreement, and there are 512,280 shares of restricted common stock that will be issued in satisfaction of the Company’s obligation under those agreements. 

 

On October 24, 2018 the Company entered into stock subscription agreements with two individuals under which they may purchase up to $35,000 in shares of common stock at $0.25 per share.  The Company accepted $35,000 under those agreements on October 24, 2018, and there are 140,000 shares of restricted common stock that will be issued in satisfaction of the Company’s obligation under those agreements. 

 

The Company has evaluated subsequent events pursuant to ASC Topic 855 and has determined that there are no events that require disclosure as of the date of issuance.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization and Description of Business (Policies)
9 Months Ended
Sep. 30, 2018
Policies  
Accounting Method

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

a. Basis of Interim Financial Statement Presentation

 

The accompanying unaudited financial statements have been prepared by the Company pursuant to accounting principles generally accepted in the United States of America.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with rules and regulations of the Securities and Exchange Commission.  The information furnished in the interim financial statements includes normal recurring adjustments and reflects all adjustments which, in the opinion of management, are necessary for a fair presentation of such financial statements.  Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim financial statements be read in conjunction with the Company’s most recent audited financial statements and notes thereto included in its December 31, 2017 financial statements.  Operating results for the three and nine months ended September 30, 2018 are not necessarily indicative of the results that may be expected for the year ending December 31, 2018.

Reclassification of operating expenses

b. Reclassification of operating expenses

 

The Company has made a reclassification of the 2017 operating expenses that affects general and administrative expense and professional and consulting fees.  In the previously published 2017 financial statement presentations legal fees were included in general and administrative expenses.  In these accompanying unaudited financial statements those legal expenses have been reclassified to professional and consulting fees for comparative purposes, as in the 2018 financial presentation legal fees are included in the professional and consulting fee operating expenses.

Revenue Recognition

 

c. Revenue Recognition

 

The Company is currently developing its products. It is anticipated that revenue will be recognized on product sales once the product has been shipped to the customers, persuasive evidence of an agreement exists, the price is fixed or determinable, and collectability is reasonably assured.

Estimates

 

d. Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

Fair Value

 

e. Fair Value

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  FASB Accounting Standards Codification (“ASC”) Topic 820 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 

Level 1 - Quoted market prices in active markets for identical assets or liabilities;

 

Level 2 - Inputs other than level one inputs that are either directly or indirectly observable; and

 

Level 3 - Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

 

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is observable.

 

All cash, accounts receivable, accounts payable and accrued liabilities are carried at cost, which approximates fair value due to the short-term nature of these financial instruments.  Additionally, we measure certain financial instruments at fair value on a recurring basis.

Cash and Cash Equivalents

 

f. Cash and Cash Equivalents

 

The Company considers all deposit accounts and investment accounts with an original maturity of 90 days or less to be cash equivalents.  

Property and equipment

 

g. Property and Equipment

 

Property and equipment items are stated at cost.  Expenditure for minor repairs, maintenance, and replacement parts which do not increase the useful lives of the assets are charged to expense as incurred. Expenditures exceeding $500 for new assets, or that increase the useful life of existing assets, are capitalized.  Depreciation is computed using the straight-line method.  The lives over which the property and equipment is depreciated are five to seven years.

Earnings Per Share

 

h. Earnings per Share

 

The computation of earnings per share of common stock is based on the weighted average number of shares outstanding during the period of the financial statement as follows:

 

Diluted earnings per share is computed using the weighted average number of common shares plus dilutive common share equivalents outstanding during the period.  For the three months ended September 30, 2018 and September 30, 2017 there were no common stock equivalents from outstanding convertible notes included in the calculation.  For the nine months ended September 30, 2018 and September 30, 2017 there were 0 and 39,076,600 common stock equivalents from outstanding notes included in the calculation.  As of September 30, 2018 there were 32,294,231 potentially dilutive shares related to convertible notes and 3,152,950 potentially dilutive shares related to subscription payables that needed to be considered as common stock equivalents.  The common stock equivalents were excluded from the calculation of diluted earnings per share because the effect these common stock equivalents would have been anti-dilutive as of September 30, 2018.

 

Earnings per share are shown, both basic and diluted, on the statement of operations.

Income Taxes

 

i. Income Taxes

 

Deferred taxes are provided on an asset and liability approach whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

Equity Instruments Issued For Non-cash Items

 

j. Equity Instruments Issued for Non-Cash Items

 

In accordance with ASC Topic 718, the Company records equity instruments issued for non-cash items at the grant-date fair value of the equity instruments issued.

New Accounting Pronouncements

 

k. Recent Accounting Pronouncements

 

reduced the U.S. federal corporate tax rate from 35% to 21% effective January 1, 2018.  Also, on December 22, 2017, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 118 (“SAB 118”), which provides guidance on accounting for tax effects of the Tax Act.  SAB 118 provides a measurement period of up to one year from the enactment date to complete the accounting.  Any adjustments during this measurement period will be included in net earnings from continuing operations as an adjustment to income tax expense in the reporting period when such adjustments are determined.  As the Company has net operating loss carryforwards which will offset tax liability for the coming year or years, no adjustments for the effect of the income tax rate change is reflected in our financial statements.

 

In February 2018, the Financial Standards Accounting Board (“FASB”) issued Accounting Statement Update No. 2018-02, “Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.”  This ASU allows a reclassification from accumulated other comprehensive income (“AOCI”) to retained earnings for certain income tax effects stranded in AOCI as a result of the Tax Act.  The reclassification eliminates the stranded tax effects resulting from the Tax Act and is intended to improve the usefulness of information reported to financial statement users.  ASU No. 2018-02 is effective for reporting periods beginning on January 1, 2019; early adoption is permitted. The Company does not currently have amounts to be reclassified under this and therefore believes it will not have an impact on its financial statements and statements of operations.

 

In June 2018, the FASB issued ASU No. 2018-07, “Compensation — Stock Compensation (Topic 718),” (“ASU 2018-07”). ASU 2018-07 is intended to reduce cost and complexity of financial reporting for non-employee share-based payments. Currently, the accounting requirements for non-employee and employee share-based payments are significantly different. ASU 2018-07 expands the scope of Topic 718, which currently only includes share-based payments to employees, to include share-based payments to non-employees for goods or services. Consequently, the accounting for share-based payments to non-employees and employees will be substantially aligned. This ASU supersedes Subtopic 505-50, “Equity — Equity-Based Payments to Nonemployees”. The amendments to ASU 2018 - 07 are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than a company’s adoption date of ASU No. 2014-09, (Topic 606), “Revenue from Contracts with Customers”. The Company is currently evaluating ASU 2018-07 and its impact on its condensed consolidated financial statements or disclosures.

 

In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders' equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders' equity presented in the balance sheet must be provided in a note or separate statement. The analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. This final rule is effective on November 5, 2018. The Company is in the process of evaluating the impact of the final rule on its consolidated financial statements.

 

The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows.  Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property and Equipment (Tables)
9 Months Ended
Sep. 30, 2018
Tables/Schedules  
Property, Plant and Equipment

 

September 30, 2018

 

December 31, 2017

 

 

 

 

 

 

Equipment

$                   90,368

 

$                      85,343

 

Accumulated depreciation

 (49,803)

 

 (38,834)

 

 

 

 

 

 

Total Fixed Assets

$                    40,565

 

                      46,509

 

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies (Tables)
9 Months Ended
Sep. 30, 2018
Tables/Schedules  
Schedule of Future Minimum Lease Payments for Capital Leases

 

    2018

    2019

    2020

Office lease

  $    3,024

$         8,063  

$                   -  

Equipment lease

 

 

2018

2019

2020

Equipment lease

 $    3,042

12,167

$                   -  

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization and Description of Business (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Details          
Outstanding common stock equivalents 0 0 0 39,076,600  
Convertible Notes Dilutive Shares     32,294,231    
Stock Issued During Period, Shares, Period Increase (Decrease)     3,152,950    
Accumulated deficit $ 5,352,452   $ 5,352,452   $ 4,504,563
Planned expenditures     $ 1,200,000    
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property and Equipment (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Details          
Property, Plant and Equipment, Gross $ 90,368   $ 90,368   $ 85,343
Accumulated Depreciation (49,803)   (49,803)   (38,834)
Property and equipment, net 40,565   40,565   $ 46,509
Depreciation expense $ 3,581 $ 3,586 $ 10,969 $ 8,958  
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Preferred and Common Stock (Details) - USD ($)
1 Months Ended 9 Months Ended
Sep. 02, 2017
Oct. 31, 2018
Sep. 30, 2018
Feb. 28, 2018
Feb. 28, 2017
Sep. 30, 2018
Sep. 30, 2017
Oct. 24, 2018
May 02, 2018
Dec. 31, 2017
Details                    
Preferred Stock, Shares Authorized     10,000,000     10,000,000       10,000,000
Preferred Stock, Par or Stated Value Per Share     $ 0.001     $ 0.001       $ 0.001
Common Stock, Share Subscribed but Unissued, Subscriptions Receivable     $ 789,175     $ 789,175        
Stock Issued During Period, Shares, Period Increase (Decrease)           3,152,950        
Stock Issued During Period, Value, New Issues         $ 700,000          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $ 0.25   $ 0.25     $ 0.25   $ 0.25 $ 0.25  
Proceeds from issuance of common stock       $ 693,605   $ 110,000 $ 729,705      
Total stock subscription shares       2,774,420            
Common Stock, Shares Subscribed but Unissued     2,734,420     2,734,420        
400,000 Stock Subscription Amount           $ 400,000        
400,000 Amount Used From Subscription   $ 128,070       $ 103,070        
Remaining Shares Under $400,000 Stock Purchase Agreement 412,280 512,280                
Merrell stock compensation           2,000,000        
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures     650,000     500,000        
Services Rendered for Subscription Receivable           $ 150,000        
110,000 Stock Subscription Shares           440,000        
110,000 Stock Subscription Amount           $ 110,000        
Consulting stock compensation 1           150,000        
Consulting stock compensation 2           500,000        
Stock issued for services performed           $ 309,000 $ 24,949      
Other Prepaid Expense, Current     $ 330,000     $ 330,000        
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Convertible Notes and Derivative Liability (Details) - USD ($)
9 Months Ended
Sep. 30, 2018
Dec. 31, 2017
Nov. 12, 2012
Details      
SCS convertible promissory note principal $ 35,762 $ 31,629 $ 100,000
SCS convertible promissory note interest rate 5.50%    
SCS convertible promissory note conversion price $ 0.01    
130,100 convertible promissory note interest rate 8.00%    
130,100 convertible promissory note conversion price $ 0.01    
130,100 convertible promissory note principal balace $ 130,100    
130,100 convertible promissory note accrued interest $ 57,774 $ 49,953  
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies (Details) - USD ($)
7 Months Ended 9 Months Ended 12 Months Ended
May 31, 2018
Sep. 30, 2018
Jun. 30, 2019
Details      
monthly office lease payment $ 978 $ 950 $ 1,008
Capital Leases, Future Minimum Payments Due   3,024  
Capital Leases, Future Minimum Payments Due in Two Years   8,063  
monthly equipment lease payment   1,014  
Other Commitments, Future Minimum Payments, Remainder of Fiscal Year   3,042  
Other Commitment, Due in Second Year   $ 12,167  
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events (Details) - USD ($)
1 Months Ended 9 Months Ended
Sep. 02, 2017
Oct. 31, 2018
Sep. 30, 2018
Oct. 24, 2018
May 02, 2018
Details          
400,000 Stock Subscription Amount     $ 400,000    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $ 0.25   $ 0.25 $ 0.25 $ 0.25
Additional Subscription Under $400,000 Stock Purchase Agreement   $ 25,000      
400,000 Amount Used From Subscription   $ 128,070 $ 103,070    
Remaining Shares Under $400,000 Stock Purchase Agreement 412,280 512,280      
140,000 Stock Subscription Amount   $ 35,000      
140,000 Stock Subscription Shares   140,000      
EXCEL 31 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 32 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 33 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 35 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 21 148 1 false 0 0 false 4 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://none/20180930/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 000020 - Statement - Condensed Balance Sheets Sheet http://none/20180930/role/idr_CondensedBalanceSheets Condensed Balance Sheets Statements 2 false false R3.htm 000030 - Statement - Condensed Balance Sheets - Parenthetical Sheet http://none/20180930/role/idr_CondensedBalanceSheetsParenthetical Condensed Balance Sheets - Parenthetical Statements 3 false false R4.htm 000040 - Statement - Condensed Statements of Operations Sheet http://none/20180930/role/idr_CondensedStatementsOfOperations Condensed Statements of Operations Statements 4 false false R5.htm 000050 - Statement - Condensed Statements of Cash Flows Sheet http://none/20180930/role/idr_CondensedStatementsOfCashFlows Condensed Statements of Cash Flows Statements 5 false false R6.htm 000060 - Disclosure - Organization and Description of Business Sheet http://none/20180930/role/idr_DisclosureOrganizationAndDescriptionOfBusiness Organization and Description of Business Notes 6 false false R7.htm 000070 - Disclosure - Property and Equipment Sheet http://none/20180930/role/idr_DisclosurePropertyAndEquipment Property and Equipment Notes 7 false false R8.htm 000080 - Disclosure - Preferred and Common Stock Sheet http://none/20180930/role/idr_DisclosurePreferredAndCommonStock Preferred and Common Stock Notes 8 false false R9.htm 000090 - Disclosure - Convertible Notes and Derivative Liability Notes http://none/20180930/role/idr_DisclosureConvertibleNotesAndDerivativeLiability Convertible Notes and Derivative Liability Notes 9 false false R10.htm 000100 - Disclosure - Commitments and Contingencies Sheet http://none/20180930/role/idr_DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 10 false false R11.htm 000110 - Disclosure - Subsequent Events Sheet http://none/20180930/role/idr_DisclosureSubsequentEvents Subsequent Events Notes 11 false false R12.htm 000120 - Disclosure - Organization and Description of Business (Policies) Sheet http://none/20180930/role/idr_DisclosureOrganizationAndDescriptionOfBusinessPolicies Organization and Description of Business (Policies) Policies 12 false false R13.htm 000130 - Disclosure - Property and Equipment (Tables) Sheet http://none/20180930/role/idr_DisclosurePropertyAndEquipmentTables Property and Equipment (Tables) Tables http://none/20180930/role/idr_DisclosurePropertyAndEquipment 13 false false R14.htm 000140 - Disclosure - Commitments and Contingencies (Tables) Sheet http://none/20180930/role/idr_DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://none/20180930/role/idr_DisclosureCommitmentsAndContingencies 14 false false R15.htm 000150 - Disclosure - Organization and Description of Business (Details) Sheet http://none/20180930/role/idr_DisclosureOrganizationAndDescriptionOfBusinessDetails Organization and Description of Business (Details) Details http://none/20180930/role/idr_DisclosureOrganizationAndDescriptionOfBusinessPolicies 15 false false R16.htm 000160 - Disclosure - Property and Equipment (Details) Sheet http://none/20180930/role/idr_DisclosurePropertyAndEquipmentDetails Property and Equipment (Details) Details http://none/20180930/role/idr_DisclosurePropertyAndEquipmentTables 16 false false R17.htm 000170 - Disclosure - Preferred and Common Stock (Details) Sheet http://none/20180930/role/idr_DisclosurePreferredAndCommonStockDetails Preferred and Common Stock (Details) Details http://none/20180930/role/idr_DisclosurePreferredAndCommonStock 17 false false R18.htm 000180 - Disclosure - Convertible Notes and Derivative Liability (Details) Notes http://none/20180930/role/idr_DisclosureConvertibleNotesAndDerivativeLiabilityDetails Convertible Notes and Derivative Liability (Details) Details http://none/20180930/role/idr_DisclosureConvertibleNotesAndDerivativeLiability 18 false false R19.htm 000190 - Disclosure - Commitments and Contingencies (Details) Sheet http://none/20180930/role/idr_DisclosureCommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://none/20180930/role/idr_DisclosureCommitmentsAndContingenciesTables 19 false false R20.htm 000200 - Disclosure - Subsequent Events (Details) Sheet http://none/20180930/role/idr_DisclosureSubsequentEventsDetails Subsequent Events (Details) Details http://none/20180930/role/idr_DisclosureSubsequentEvents 20 false false All Reports Book All Reports numd-20180930.xml numd-20180930.xsd numd-20180930_cal.xml numd-20180930_def.xml numd-20180930_lab.xml numd-20180930_pre.xml http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/us-gaap/2018-01-31 true true ZIP 37 0001548123-18-000314-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001548123-18-000314-xbrl.zip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end